{
  "schemaVersion": "deck-intelligence.v1",
  "id": "019de077-691b-72c2-80d2-a28de652ce70",
  "slug": "7b833127c4e1241e21c155446b1ba76b",
  "title": "MindMed | Investor Presentation Deck | 42 slides",
  "subtitle": "MindMed · 2024-12",
  "author": "MindMed",
  "date": "2024-12-01 00:00:00",
  "pageCount": 42,
  "kind": "pitchdeck",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "document": {
    "id": "019de077-691b-72c2-80d2-a28de652ce70",
    "slug": "7b833127c4e1241e21c155446b1ba76b",
    "title": "MindMed | Investor Presentation Deck | 42 slides",
    "rawTitle": "MindMed | Investor Presentation Deck | 42 slides",
    "authorId": "mindmed",
    "authorName": "MindMed",
    "authorDisplay": "MindMed",
    "kind": {
      "slug": "pitchdeck",
      "label": "Pitch deck"
    },
    "sourceType": {
      "slug": "investor_relations",
      "label": "Investor relations"
    },
    "fileName": "2024-12__mindmed__investor-pres__7b833127.pdf",
    "sourceUrl": "https://www.slidebook.io/company/mindmed/presentation/7b833127c4e1241e21c155446b1ba76b/",
    "sourceDate": "2024-12-15 00:00:00",
    "presentationDate": "2024-12-01 00:00:00",
    "ingestedAt": "2026-04-30 22:16:55.424593+00",
    "status": "ready",
    "pageCount": 42,
    "orientation": "landscape",
    "aspectRatio": 1.7777778,
    "targetCompany": null,
    "targetTicker": null,
    "metadata": {
      "corpus": "slidebook",
      "industry": "biotechnology",
      "local_root": "/Users/miguelsuredasuau/Desktop/lalalalla/_scrape/slidebook/decks/2024-12__mindmed__investor-pres__7b833127",
      "image_width": 1920,
      "image_format": "jpg",
      "deck_type_raw": "Investor Presentation Deck",
      "deck_type_slug": null,
      "source_url_pattern": "https://www.slidebook.io/company/{company_slug}/presentation/{deck_id}/"
    }
  },
  "coverage": {
    "pageCount": 42,
    "pagesIndexed": 42,
    "pagesWithImages": 42,
    "pagesWithMetadata": 42,
    "imageCoveragePct": 100,
    "metadataCoveragePct": 100,
    "componentCount": 170,
    "chartCount": 10,
    "metricSlides": 0,
    "toolMatches": 12,
    "documentToolMatches": 0,
    "frameworkMatches": 19,
    "arcMatches": 1,
    "beatMatches": 4,
    "loopMatches": 2,
    "patternMatches": 0,
    "storymakersMatch": false,
    "scoreAvailable": false,
    "reviewAvailable": false,
    "activistThesisAvailable": false,
    "pitchdeckMetadataAvailable": false,
    "pitchdeckProfileAvailable": false
  },
  "blocks": [],
  "matches": {
    "arcs": [
      {
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
        "evidence": "The document follows a structured presentation format, including sections on problem statement, solution, traction, and roadmap, which is typical of the Sequoia Pitch arc.",
        "isPrimary": true,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-16 22:45:41.836593+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      }
    ],
    "beats": [
      {
        "to": 9,
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 9,
        "name": "Problem",
        "beatId": "f03f5f70-fbfa-4fd3-bbe0-8920a77d58d6",
        "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
        "beatType": {
          "name": "Problem",
          "slug": "sequoia-pitch-problem",
          "status": "active",
          "canonId": "019dd9b8-1ed4-767b-8e05-40e733bd2311",
          "version": 1,
          "description": null
        },
        "evidence": "The problem statement is clearly presented on page 9, highlighting the need for novel therapies in brain health.",
        "position": 0,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Complication",
          "slug": "complication",
          "status": "active",
          "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
          "version": 1,
          "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 10,
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 10,
        "name": "Solution",
        "beatId": "ad646e98-f9da-4aac-992e-c74090d46632",
        "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
        "beatType": {
          "name": "Solution",
          "slug": "sequoia-pitch-solution",
          "status": "active",
          "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f",
          "version": 1,
          "description": null
        },
        "evidence": "The solution is presented on page 10, outlining the clinical rationale and mechanism of action for MM120.",
        "position": 1,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Turn",
          "slug": "turn",
          "status": "active",
          "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
          "version": 1,
          "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 36,
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 16,
        "name": "Traction",
        "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
        "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
        "beatType": null,
        "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
        "position": 2,
        "isPrimaryArc": true,
        "parentBeatType": null,
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 6,
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 5,
        "name": "Roadmap",
        "beatId": "40f4f6af-086d-4fc6-9156-6770c62bc13d",
        "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
        "beatType": null,
        "evidence": "The roadmap is presented on pages 5 and 6, outlining the next steps and anticipated milestones for the R&D pipeline.",
        "position": 3,
        "isPrimaryArc": true,
        "parentBeatType": null,
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      }
    ],
    "loops": [
      {
        "to": 10,
        "from": 9,
        "loop": {
          "name": "27_cost_of_inaction",
          "slug": "27-cost-of-inaction",
          "status": "active",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
          "version": 1,
          "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "description": "Quantify what happens if the audience does nothing",
          "familyLabel": null,
          "categoryName": "Urgency",
          "categorySlug": "urgency"
        },
        "matchId": "6e258645-fc1b-4e40-b71b-ce1ca3ac87d4",
        "evidence": "The problem statement and solution sections create a loop that emphasizes the cost of inaction and the potential benefits of MM120.",
        "position": 0,
        "objective": "Highlighting the need for novel therapies",
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 22:45:42.011832+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      },
      {
        "to": 42,
        "from": 3,
        "loop": {
          "name": "11_golden_circle",
          "slug": "11-golden-circle",
          "status": "active",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
          "version": 1,
          "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
          "familyLabel": null,
          "categoryName": "Vision",
          "categorySlug": "vision"
        },
        "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
        "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
        "position": 1,
        "objective": "Presenting the company's vision and approach",
        "confidence": 0.6,
        "extraction": {
          "at": "2026-07-16 22:45:42.047737+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      }
    ],
    "tools": [
      {
        "tool": {
          "name": "Executive summary",
          "slug": "executive-summary",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61",
          "version": 1,
          "bodyDocId": null,
          "description": "A condensed view of the entire argument on a single slide / block.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "a6f73682-14d5-4daa-a7f0-6aa0c639e696",
        "evidence": "This slide is titled 'We Aim To Be A Global Leader In Brain Health' and contains a list of bullet points and a diagram, which is typical of an executive summary.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 00:49:26.646773+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 3,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "List presentation",
          "slug": "list-presentation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
          "version": 1,
          "bodyDocId": null,
          "description": "Bulleted, numbered, or checklist enumerations.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "d3af339c-62cc-49b1-b823-933344906cc5",
        "evidence": "list/bullet: Positive 12-Week Durability in Phase 2b Trial of GAD; Breakthrough Therapy Designation for GAD; Enhanced Product Profile of MM120 ODTs; Market Protection Strategies and IP Portfolio",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 03:58:54.623937+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 8,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "2x2 matrix",
          "slug": "matrix-2x2",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8",
          "version": 1,
          "bodyDocId": null,
          "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "1b5fe7aa-e83c-42f1-9dc2-b700c9a75846",
        "evidence": "table/data: Matrix comparing GAD and MDD across Preliminary Clinical Evidence, Large Market Opportunities, and Significant Need for New Treatments.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 03:58:54.696245+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 9,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Problem Statement Canvas",
          "slug": "problem-statement-canvas",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-839d-744b-ad11-9bf3e3642a18",
          "version": 1,
          "bodyDocId": null,
          "description": "Structured definition of the problem: What? Who? Where? When? Scale?",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Architect",
        "layer": "slide",
        "agents": [
          "Architect"
        ],
        "matchId": "8aa03a82-68f4-4b59-b41d-33c4c03f1f9e",
        "evidence": "Potential Best-in-Class Therapy with Novel MOA",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.6,
        "extraction": {
          "at": "2026-07-17 03:58:54.732298+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 9,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "List presentation",
          "slug": "list-presentation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
          "version": 1,
          "bodyDocId": null,
          "description": "Bulleted, numbered, or checklist enumerations.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "81ad838e-d0ea-4fa2-9661-6ff5b4a07efe",
        "evidence": "list/bullet: Supply chain availability, Exclusive rights to key technology, Lifecycle management, Trade secrets & know-how, Differentiated product performance, Differentiated combination",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:59:11.564753+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 13,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Slide recipe: Cover",
          "slug": "cover-slide",
          "status": "active",
          "bestFor": null,
          "canonId": "019df269-2a08-767d-9128-e7431e6fe8a3",
          "version": 1,
          "bodyDocId": "019df269-29e5-7738-b5fa-6892e5dc8e65",
          "description": "The first ten seconds. Build it deliberately.",
          "familyLabel": "slide-recipe",
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "designer",
        "layer": "slide",
        "agents": [
          "designer"
        ],
        "matchId": "ac1e5acc-a849-4398-aa63-a519fbbb2b68",
        "evidence": "title/headline: MM120 ODT Lysergide D-tartrate",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 03:59:11.637974+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 14,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Chart Selection Guide",
          "slug": "chart-selection-guide",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
          "version": 1,
          "bodyDocId": null,
          "description": "Choosing the right chart type for your data and message",
          "familyLabel": null,
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "Designer",
        "layer": "slide",
        "agents": [
          "Designer"
        ],
        "matchId": "f88457fe-5006-43a6-b677-c4527347324d",
        "evidence": "chart/bar-horizontal: Comparative Effect Sizes in GAD",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.5,
        "extraction": {
          "at": "2026-07-17 03:59:11.749729+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 16,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Waterfall chart",
          "slug": "waterfall-chart",
          "status": "active",
          "bestFor": null,
          "canonId": "e2799da3-725f-44a9-a093-570f1f388e64",
          "version": 1,
          "bodyDocId": null,
          "description": null,
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "a8662c2b-8b6c-4fdb-9662-9d32956261a5",
        "evidence": "chart/line: MADRS Change from Baseline",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 00:49:26.147726+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 24,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Customer journey map",
          "slug": "customer-journey-map",
          "status": "active",
          "bestFor": null,
          "canonId": "019de52d-1b26-7499-98c8-1091acc836be",
          "version": 1,
          "bodyDocId": null,
          "description": null,
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "cc0e0309-3c77-481b-9522-386b2c1b49f4",
        "evidence": "Treatment Paradigm: Standalone Drug Effects with No Psychotherapeutic Intervention",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 00:49:26.432405+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 30,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Chartjunk Elimination",
          "slug": "chartjunk-elimination",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-b49e-7453-ab01-b60f338eeda1",
          "version": 1,
          "bodyDocId": null,
          "description": "Remove decorative elements that don't convey data: 3D effects, shadows, unnecessary gridlines",
          "familyLabel": null,
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "Designer",
        "layer": "slide",
        "agents": [
          "Designer"
        ],
        "matchId": "8ca2c4ad-0213-427b-bb69-b1181a4e6c72",
        "evidence": "The chart effectively communicates the data with a clear and simple bar chart.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:41:09.395396+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 36,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "List presentation",
          "slug": "list-presentation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
          "version": 1,
          "bodyDocId": null,
          "description": "Bulleted, numbered, or checklist enumerations.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "f0b38644-7847-4291-9e14-d29efeca0864",
        "evidence": "The slide uses a list/bullet format to present information.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:41:09.47464+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 37,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Table data",
          "slug": "table-data",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4fab-7168-a82f-b847350a006d",
          "version": 1,
          "bodyDocId": null,
          "description": "Tabular layouts of structured data.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "333564e8-1de2-4f1e-a071-1ef4a729ee57",
        "evidence": "The slide contains a table with data.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:41:09.553373+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 38,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      }
    ],
    "frameworks": [
      {
        "matchId": "0f565394-c10e-4957-bcab-ee2cb7d647d2",
        "evidence": "Central brand logo surrounded by five strategic pillars",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 10:50:55.026+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 3,
        "frameworkName": "hub-spoke"
      },
      {
        "matchId": "1e727143-b46d-427a-947c-2aefad1194b2",
        "evidence": "The pipeline is visualized as a horizontal bar chart mapping progress over clinical phases.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 10:50:53.365+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 5,
        "frameworkName": "gantt-chart"
      },
      {
        "matchId": "881c7c5b-4efc-4bd6-b7fd-1e92e43fa162",
        "evidence": "The slide uses a horizontal timeline to map project milestones over time.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 10:50:53.48+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 6,
        "frameworkName": "gantt-chart"
      },
      {
        "matchId": "7f2b97f0-060f-4cb7-8072-dbf36115465a",
        "evidence": "3x2 grid comparing clinical, market, and need factors across two disease states.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 10:50:53.97+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 9,
        "frameworkName": "matrix-nxn"
      },
      {
        "matchId": "8938da90-d17a-43b8-93c4-f073b05499c6",
        "evidence": "Shows the sequence from drug binding to receptor to clinical outcome",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 10:50:54.206+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 10,
        "frameworkName": "causal-chain"
      },
      {
        "matchId": "6e6c0802-bed8-437a-b673-ae94acc7007f",
        "evidence": "The slide uses a horizontal timeline to show protection duration.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 10:50:55.47+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 13,
        "frameworkName": "timeline"
      },
      {
        "matchId": "5ef1dcc1-c928-4ee2-88d5-220bcc33152a",
        "evidence": "Direct comparison of effect sizes between proprietary drug and standard of care.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 10:50:55.407+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 16,
        "frameworkName": "comparison_frame"
      },
      {
        "matchId": "f71c9664-7497-4d73-b08f-1bad40ff560d",
        "evidence": "The slide uses a structured list to present key clinical findings against product profile attributes.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 10:50:54.93+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 17,
        "frameworkName": "list-presentation"
      },
      {
        "matchId": "50165c70-be92-4973-bed8-aed6411e1188",
        "evidence": "Visual flow of clinical trial phases",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 10:50:56.952+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 18,
        "frameworkName": "process"
      },
      {
        "matchId": "8b6902b9-4dcd-469a-9c5d-3dcc602e20eb",
        "evidence": "Timeline visualization of clinical trial phases",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 10:50:59.343+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 19,
        "frameworkName": "gantt-chart"
      },
      {
        "matchId": "ed723333-e77e-4f21-bf46-ca998e71341a",
        "evidence": "Flowchart showing clinical trial phases and decision criteria",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 10:50:59.207+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 20,
        "frameworkName": "process"
      },
      {
        "matchId": "ccf62092-bea6-4c54-9c5c-f2d06be0deff",
        "evidence": "Citing specific clinical studies to validate the therapeutic potential of the product.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 10:50:56.017+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 23,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "cf892d25-f425-4339-8241-332e5c4894b2",
        "evidence": "The slide maps out the phases, arms, and endpoints of a clinical study.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 10:50:56.974+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 25,
        "frameworkName": "clinical-trial-design"
      },
      {
        "matchId": "010d6518-3fd7-4936-8cbf-d37806228092",
        "evidence": "Visual timeline of clinical trial phases",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 10:50:56.28+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 26,
        "frameworkName": "gantt-chart"
      },
      {
        "matchId": "d2d78c19-c6f0-4d19-b338-a643f48d7e61",
        "evidence": "Visual timeline of clinical trial phases",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 10:50:56.952+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 29,
        "frameworkName": "gantt-chart"
      },
      {
        "matchId": "fcafa79e-1bad-40ca-9910-ecdedd5c8ff1",
        "evidence": "The table maps the patient experience across three distinct phases of the clinical trial.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 10:50:56.762+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 30,
        "frameworkName": "customer-journey-map"
      },
      {
        "matchId": "4428c2a6-94b6-4df4-8959-9a01e06fad4f",
        "evidence": "Standard clinical trial participant disposition reporting structure",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 10:50:57.271+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 31,
        "frameworkName": "CONSORT flow diagram"
      },
      {
        "matchId": "76c235bd-8551-4270-af82-c103566bbfbd",
        "evidence": "Explicitly mentioned in title and takeaways as the statistical methodology used.",
        "framework": null,
        "confidence": 1,
        "extraction": {
          "at": "2026-05-02 10:50:57.631+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 35,
        "frameworkName": "MCP-Mod"
      },
      {
        "matchId": "b389321e-53fc-417f-ba4d-519427354166",
        "evidence": "Use of icons to categorize benefits",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 10:50:58.848+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 41,
        "frameworkName": "iconography"
      }
    ],
    "patterns": []
  },
  "storymakers": null,
  "score": null,
  "review": null,
  "activistThesis": null,
  "pitchdeck": {
    "metadata": null,
    "profile": null
  },
  "slides": [
    {
      "page": 1,
      "type": "setup",
      "function": "front_matter",
      "imagePath": "https://imgproxy.kitesheet.com/GmFF1Q1XvzIAKaUJhZXUzM50HaqqmFRl9VGEKAt5Q5A/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83YjgzMzEyN2M0ZTEyNDFlMjFjMTU1NDQ2YjFiYTc2Yi9wMDAxLmpwZw",
      "rawType": "cover",
      "block": null,
      "metadata": {
        "slideType": "cover",
        "slideTypeCanon": {
          "name": "Cover",
          "slug": "cover",
          "status": "active",
          "canonId": "019de52d-05f2-729d-9f93-e0504f0a2410",
          "version": 1,
          "description": null
        },
        "function": "front_matter",
        "functionCanon": {
          "name": "Front matter",
          "slug": "front_matter",
          "status": "active",
          "canonId": "019de52d-133d-73f0-9e26-201eda96b098",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 10,
        "componentCount": 3,
        "textChars": 42,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:52.844+00",
          "seconds": 2.067,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/1",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-1",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.074,
            "w": 0.298,
            "x": 0.627,
            "y": 0.232
          },
          "kind": "image",
          "text": "MindMed",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:52.844+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "581ed970-0dc4-4961-b801-a4e8349d6929",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.115,
            "x": 0.651,
            "y": 0.675
          },
          "kind": "paragraph",
          "text": "December 2024",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:52.844+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d5463f74-cda2-41b1-8c4d-f67997130092",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.25,
            "x": 0.651,
            "y": 0.585
          },
          "kind": "title",
          "text": "Corporate Presentation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:52.844+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "94742c48-7678-438f-9271-07ebf296beb6",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "thumbSrc": "https://imgproxy.kitesheet.com/JPckh037niyXf_zv5_oWQXniDI0q4t4Tdd-IgJXuwKg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83YjgzMzEyN2M0ZTEyNDFlMjFjMTU1NDQ2YjFiYTc2Yi9wMDAxLmpwZw",
      "imagePathAlt": "https://imgproxy.kitesheet.com/5uD0fjKEmxwphr4J5SOaPQ0GbRGetk8ZMZcCX002MyE/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83YjgzMzEyN2M0ZTEyNDFlMjFjMTU1NDQ2YjFiYTc2Yi9wMDAxLnBuZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/HmMDIeMCHzl4c30uraZsJQVByYGfiWeegMnXUEAx-lI/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83YjgzMzEyN2M0ZTEyNDFlMjFjMTU1NDQ2YjFiYTc2Yi9wMDAxLnBuZw"
    },
    {
      "page": 2,
      "type": "setup",
      "function": "other",
      "rawType": "disclaimer",
      "block": null,
      "metadata": {
        "slideType": "disclaimer",
        "slideTypeCanon": {
          "name": "Disclaimer",
          "slug": "disclaimer",
          "status": "active",
          "canonId": "019de52d-0801-727b-b98a-5ed095aeee78",
          "version": 1,
          "description": null
        },
        "function": "other",
        "functionCanon": {
          "name": "Other (fallback)",
          "slug": "other",
          "status": "active",
          "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 8,
        "componentCount": 2,
        "textChars": 102,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:52.869+00",
          "seconds": 2.079,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/2",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-2",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.75,
            "w": 0.9,
            "x": 0.05,
            "y": 0.14
          },
          "kind": "disclaimer",
          "text": "This presentation (the “Presentation”) has been prepared by Mind Medicine (MindMed) Inc. ...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:52.869+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1bc789c4-391b-44fa-a9f3-a5326f72db88",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.15,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "Disclaimer",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:52.869+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0aa36f5b-c1c1-4379-acfe-974eaa44dcaf",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 3,
      "type": "setup",
      "title": "The slide uses a hub-and-spoke diagram to centralize the company brand around five key strategic pillars.",
      "function": "summarize",
      "rawType": "executive_summary",
      "block": null,
      "metadata": {
        "slideType": "executive_summary",
        "slideTypeCanon": {
          "name": "Executive summary",
          "slug": "executive_summary",
          "status": "active",
          "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 81,
        "componentCount": 8,
        "textChars": 746,
        "nDataPoints": 1,
        "notes": "The slide uses a hub-and-spoke diagram to centralize the company brand around five key strategic pillars.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:55.026+00",
          "seconds": 4.132,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/3",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-3",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.48,
            "w": 0.43,
            "x": 0.285,
            "y": 0.18
          },
          "kind": "diagram",
          "text": "MindMed central hub with five surrounding strategic pillars",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Hub and spoke",
              "slug": "hub-spoke",
              "status": "active",
              "canonId": "019de52d-04db-73e6-81ca-a234f2f23fc1",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "hub-spoke",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.026+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6d0ee29c-a3e3-4407-b56c-360164884ad7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.33,
            "x": 0.075,
            "y": 0.5
          },
          "kind": "list",
          "text": "Research: Leveraging decades of preclinical and clinical research with promising results in Phase 2b; Phase 3 program underway",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.026+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3b4c6fbc-66b2-4b3d-ad91-8c3878810373",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.2,
            "x": 0.76,
            "y": 0.225
          },
          "kind": "list",
          "text": "Management: Expertise in neuroscience drug development and commercialization",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.026+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "44a2ca55-4b4f-4592-ba6c-49d09ecad2f1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.28,
            "x": 0.075,
            "y": 0.225
          },
          "kind": "list",
          "text": "Pipeline: Diversified pipeline of clinical programs targeting significant unmet medical needs",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.026+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "947e7fe3-b0dc-499a-aaef-14d5dd98857f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.25,
            "x": 0.71,
            "y": 0.5
          },
          "kind": "list",
          "text": "Expected Runway: Expected cash runway through key clinical readouts and into 2027",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.026+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b137f75f-2226-407d-98b4-e61ed150b4af",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.25,
            "x": 0.38,
            "y": 0.69
          },
          "kind": "list",
          "text": "Market Protection Strategies: IP and R&D strategies intended to maximize market exclusivity and protection",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.026+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e4447988-fe82-42be-a011-49fe576b6986",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.7,
            "x": 0.145,
            "y": 0.935
          },
          "kind": "source-note",
          "text": "1. The company's cash and cash equivalents of $295.3 million as of September 30, 2024, expected to fund operations into 2027 based on our current operating plan.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.026+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "57b507f9-08be-474a-83e8-d48a92fcb915",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.045,
            "w": 0.563,
            "x": 0.037,
            "y": 0.045
          },
          "kind": "title",
          "text": "We Aim To Be A Global Leader In Brain Health",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.026+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c6e5fa01-2f1b-4c81-9fda-e56bca4b5ae0",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Executive summary",
            "slug": "executive-summary",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61",
            "version": 1,
            "bodyDocId": null,
            "description": "A condensed view of the entire argument on a single slide / block.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "a6f73682-14d5-4daa-a7f0-6aa0c639e696",
          "evidence": "This slide is titled 'We Aim To Be A Global Leader In Brain Health' and contains a list of bullet points and a diagram, which is typical of an executive summary.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 00:49:26.646773+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 3,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "0f565394-c10e-4957-bcab-ee2cb7d647d2",
          "evidence": "Central brand logo surrounded by five strategic pillars",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 10:50:55.026+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 3,
          "frameworkName": "hub-spoke"
        }
      ],
      "arcBeats": [],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 4,
      "type": "setup",
      "title": "The slide combines team headshots with a list of pharmaceutical products they have worked on and a list of previous company affiliations.",
      "function": "other",
      "rawType": "team_bio",
      "block": null,
      "metadata": {
        "slideType": "team_bio",
        "slideTypeCanon": {
          "name": "Team bio",
          "slug": "team_bio",
          "status": "active",
          "canonId": "019de52d-0a7d-7394-ae5b-037478e71f1e",
          "version": 1,
          "description": null
        },
        "function": "other",
        "functionCanon": {
          "name": "Other (fallback)",
          "slug": "other",
          "status": "active",
          "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 46,
        "componentCount": 6,
        "textChars": 239,
        "nDataPoints": 0,
        "notes": "The slide combines team headshots with a list of pharmaceutical products they have worked on and a list of previous company affiliations.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:53.695+00",
          "seconds": 2.775,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/4",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-4",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.55,
            "w": 0.65,
            "x": 0.05,
            "y": 0.15
          },
          "kind": "image",
          "text": "8 executive headshots",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Headshot",
              "slug": "headshot",
              "status": "active",
              "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.695+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "15c8bf35-112e-4c9b-b3eb-65d701215ac3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.65,
            "w": 0.2,
            "x": 0.75,
            "y": 0.18
          },
          "kind": "image",
          "text": "Product logos and names",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo grid",
              "slug": "logo-grid",
              "status": "active",
              "canonId": "019de52c-fdd7-7409-93e5-81280a8ca215",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo-grid",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.695+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "31b4ff46-bd75-4150-b2b3-a1245588c9a5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.65,
            "x": 0.05,
            "y": 0.75
          },
          "kind": "image",
          "text": "List of pharmaceutical company logos",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo grid",
              "slug": "logo-grid",
              "status": "active",
              "canonId": "019de52c-fdd7-7409-93e5-81280a8ca215",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo-grid",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.695+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f99fc39f-0521-4d3b-9e44-7ffffa0420b5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.2,
            "x": 0.75,
            "y": 0.08
          },
          "kind": "list",
          "text": "Strong Experience in Brain Health Innovation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.695+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fe7be6f7-e48e-4b21-9cb1-3cc538cd11c5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.3,
            "x": 0.17,
            "y": 0.94
          },
          "kind": "source-note",
          "text": "1. Representative of approved drugs developed by MindMed employees",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.695+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9d6756cd-0eef-4666-9100-c286b1f29052",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.5,
            "x": 0.04,
            "y": 0.04
          },
          "kind": "title",
          "text": "Experienced Leadership with a Proven Track Record",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.695+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8422c044-9c0e-441a-993e-ebf29d8f8683",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 5,
      "type": "resolution",
      "title": "The chart uses a Gantt-style visualization to represent clinical trial progress.",
      "function": "plan_implementation",
      "rawType": "roadmap",
      "block": null,
      "metadata": {
        "slideType": "roadmap",
        "slideTypeCanon": {
          "name": "Roadmap",
          "slug": "roadmap",
          "status": "active",
          "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 40,
        "componentCount": 4,
        "textChars": 432,
        "nDataPoints": 0,
        "notes": "The chart uses a Gantt-style visualization to represent clinical trial progress.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:53.365+00",
          "seconds": 2.447,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/5",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-5",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.48,
            "w": 0.41,
            "x": 0.39,
            "y": 0.26
          },
          "kind": "chart",
          "text": "Horizontal bars representing clinical trial progress for MM120 and MM402.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Horizontal bar chart",
              "slug": "bar-horizontal",
              "status": "active",
              "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-horizontal",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.365+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1c7648e7-e63e-4e75-b5fd-802554f7ce91",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.43,
            "x": 0.168,
            "y": 0.925
          },
          "kind": "source-note",
          "text": "1. Full trial details and clinicaltrials.gov links available at mindmed.co/clinical-digital-trials/ 2. Studies in exploration and/or planning stage. LSD: lysergide; R(-)-MDMA: rectus-3,4-methylenedioxymethamphetamine",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.365+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bea1e952-f302-4593-b560-2edd6decf519",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.65,
            "w": 0.928,
            "x": 0.036,
            "y": 0.185
          },
          "kind": "table",
          "text": "Pipeline table showing Product Candidate, Indication, and clinical phases (Preclinical to Registration).",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.365+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "13a2975d-8000-4ca8-b938-618ee58e4652",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.55,
            "x": 0.038,
            "y": 0.048
          },
          "kind": "title",
          "text": "MindMed Research & Development Pipeline",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.365+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "16f9a671-1925-4930-88c8-a305d331be7b",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "1e727143-b46d-427a-947c-2aefad1194b2",
          "evidence": "The pipeline is visualized as a horizontal bar chart mapping progress over clinical phases.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 10:50:53.365+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 5,
          "frameworkName": "gantt-chart"
        }
      ],
      "arcBeats": [
        {
          "to": 6,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 5,
          "name": "Roadmap",
          "beatId": "40f4f6af-086d-4fc6-9156-6770c62bc13d",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The roadmap is presented on pages 5 and 6, outlining the next steps and anticipated milestones for the R&D pipeline.",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 6,
      "type": "resolution",
      "title": "The slide uses a horizontal timeline format to track clinical trial milestones.",
      "function": "plan_implementation",
      "rawType": "roadmap",
      "block": null,
      "metadata": {
        "slideType": "roadmap",
        "slideTypeCanon": {
          "name": "Roadmap",
          "slug": "roadmap",
          "status": "active",
          "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 14,
        "componentCount": 3,
        "textChars": 117,
        "nDataPoints": 0,
        "notes": "The slide uses a horizontal timeline format to track clinical trial milestones.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:53.48+00",
          "seconds": 2.533,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/6",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-6",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.78,
            "w": 0.92,
            "x": 0.04,
            "y": 0.11
          },
          "kind": "chart",
          "text": "Timeline of R&D milestones",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "timeline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.48+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "122ea2d7-e936-44c8-9423-5ac6ce72e127",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.78,
            "w": 0.92,
            "x": 0.04,
            "y": 0.11
          },
          "kind": "framework",
          "text": "Timeline of clinical trial milestones",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Framework",
              "slug": "framework",
              "status": "active",
              "canonId": "019de52c-fa18-77c6-b10a-ccb8277ac0fa",
              "version": 1,
              "description": "Named conceptual framework instance."
            },
            "tool": null,
            "subkind": {
              "name": "Framework instance",
              "slug": "instance",
              "status": "active",
              "canonId": "019de52d-05a2-72af-be0b-7edc60708a03",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "instance",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.48+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9e1c7822-791c-4531-abf3-2afc25bae8fc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.68,
            "x": 0.038,
            "y": 0.048
          },
          "kind": "title",
          "text": "Next Steps and Anticipated Milestones for R&D Pipeline",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.48+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "32537a0d-5118-4704-9bb2-720a22202634",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "881c7c5b-4efc-4bd6-b7fd-1e92e43fa162",
          "evidence": "The slide uses a horizontal timeline to map project milestones over time.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 10:50:53.48+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 6,
          "frameworkName": "gantt-chart"
        }
      ],
      "arcBeats": [
        {
          "to": 6,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 5,
          "name": "Roadmap",
          "beatId": "40f4f6af-086d-4fc6-9156-6770c62bc13d",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The roadmap is presented on pages 5 and 6, outlining the next steps and anticipated milestones for the R&D pipeline.",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 7,
      "type": "setup",
      "function": "transition",
      "rawType": "section_divider",
      "block": null,
      "metadata": {
        "slideType": "section_divider",
        "slideTypeCanon": {
          "name": "Section divider",
          "slug": "section_divider",
          "status": "active",
          "canonId": "019de52d-066a-7402-9554-6ae504999041",
          "version": 1,
          "description": null
        },
        "function": "transition",
        "functionCanon": {
          "name": "Transition",
          "slug": "transition",
          "status": "active",
          "canonId": "019de52d-1365-7149-92aa-66df859e75fd",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 6,
        "componentCount": 2,
        "textChars": 54,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:53.309+00",
          "seconds": 2.276,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/7",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-7",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.07,
            "w": 0.298,
            "x": 0.627,
            "y": 0.232
          },
          "kind": "image",
          "text": "MindMed",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.309+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a110559b-5b1d-4da6-99a5-c4768f061aad",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.106,
            "w": 0.298,
            "x": 0.627,
            "y": 0.598
          },
          "kind": "title",
          "text": "MM120 ODT Lysergide D-tartrate Program Overview",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.309+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1df8c082-b56e-46ec-a918-99ea09d722e7",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 8,
      "type": "evidence",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 42,
        "componentCount": 3,
        "textChars": 515,
        "nDataPoints": 3,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:53.177+00",
          "seconds": 1.915,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/8",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-8",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.05,
            "w": 0.6,
            "x": 0.16,
            "y": 0.92
          },
          "kind": "disclaimer",
          "text": "1. Source: Study MMED008 internal study documents and calculations. 2. Source: https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/breakthrough-therapy. AUC: area under the curve; ODT: orally disintegrating tablet; PK: pharmacokinetic; SOC: standard of care",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.177+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "03af7841-b58d-4f50-ba86-cbf9c79c2c18",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.7,
            "w": 0.7,
            "x": 0.14,
            "y": 0.15
          },
          "kind": "list",
          "text": "Positive 12-Week Durability in Phase 2b Trial of GAD; Breakthrough Therapy Designation for GAD; Enhanced Product Profile of MM120 ODTs; Market Protection Strategies and IP Portfolio",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.177+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "497e028f-e518-4cdd-8440-191515efe3be",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.4,
            "x": 0.038,
            "y": 0.05
          },
          "kind": "title",
          "text": "Key Highlights of MM120 Program",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.177+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e856cef3-cae7-42e1-97e5-c58d32635ce9",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "List presentation",
            "slug": "list-presentation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
            "version": 1,
            "bodyDocId": null,
            "description": "Bulleted, numbered, or checklist enumerations.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "d3af339c-62cc-49b1-b823-933344906cc5",
          "evidence": "list/bullet: Positive 12-Week Durability in Phase 2b Trial of GAD; Breakthrough Therapy Designation for GAD; Enhanced Product Profile of MM120 ODTs; Market Protection Strategies and IP Portfolio",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-17 03:58:54.623937+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 8,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 9,
      "type": "tension",
      "title": "The slide uses a 3x2 matrix structure to contrast clinical efficacy, market opportunity, and current treatment limitations.",
      "function": "frame_problem",
      "rawType": "problem_statement",
      "block": null,
      "metadata": {
        "slideType": "problem_statement",
        "slideTypeCanon": {
          "name": "Problem statement",
          "slug": "problem_statement",
          "status": "active",
          "canonId": "019de52d-0879-768d-bba8-8da8a5a121d4",
          "version": 1,
          "description": null
        },
        "function": "frame_problem",
        "functionCanon": {
          "name": "Frame problem",
          "slug": "frame_problem",
          "status": "active",
          "canonId": "019de52d-13db-753e-ad70-e9b2d0dab398",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 46,
        "componentCount": 4,
        "textChars": 380,
        "nDataPoints": 8,
        "notes": "The slide uses a 3x2 matrix structure to contrast clinical efficacy, market opportunity, and current treatment limitations.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:53.97+00",
          "seconds": 2.64,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/9",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-9",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.05,
            "w": 0.72,
            "x": 0.24,
            "y": 0.16
          },
          "kind": "callout",
          "text": "Potential Best-in-Class Therapy with Novel MOA",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.97+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "be1871dd-f62d-4e7b-b34f-2728a603ccc5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.05,
            "y": 0.9
          },
          "kind": "source-note",
          "text": "1. Based on results from Phase 2b Study MMED008... 4. GAD: generalized anxiety disorder; MDD: major depressive disorder...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.97+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c7ca5e0a-b993-4027-a7f8-f404304a14d0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.65,
            "w": 0.9,
            "x": 0.05,
            "y": 0.23
          },
          "kind": "table",
          "text": "Matrix comparing GAD and MDD across Preliminary Clinical Evidence, Large Market Opportunities, and Significant Need for New Treatments.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.97+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e4b5d6f5-c964-405a-8ea3-b6e69fb7ce41",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "MM120: Potential to Address Large Unmet Needs in Major Brain Health Disorders",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.97+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dc92a998-870c-46e2-bb63-67f42102b6e8",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "2x2 matrix",
            "slug": "matrix-2x2",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8",
            "version": 1,
            "bodyDocId": null,
            "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "1b5fe7aa-e83c-42f1-9dc2-b700c9a75846",
          "evidence": "table/data: Matrix comparing GAD and MDD across Preliminary Clinical Evidence, Large Market Opportunities, and Significant Need for New Treatments.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-17 03:58:54.696245+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 9,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        },
        {
          "tool": {
            "name": "Problem Statement Canvas",
            "slug": "problem-statement-canvas",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-839d-744b-ad11-9bf3e3642a18",
            "version": 1,
            "bodyDocId": null,
            "description": "Structured definition of the problem: What? Who? Where? When? Scale?",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Architect",
          "layer": "slide",
          "agents": [
            "Architect"
          ],
          "matchId": "8aa03a82-68f4-4b59-b41d-33c4c03f1f9e",
          "evidence": "Potential Best-in-Class Therapy with Novel MOA",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-17 03:58:54.732298+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 9,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "7f2b97f0-060f-4cb7-8072-dbf36115465a",
          "evidence": "3x2 grid comparing clinical, market, and need factors across two disease states.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 10:50:53.97+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 9,
          "frameworkName": "matrix-nxn"
        }
      ],
      "arcBeats": [
        {
          "to": 9,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 9,
          "name": "Problem",
          "beatId": "f03f5f70-fbfa-4fd3-bbe0-8920a77d58d6",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": {
            "name": "Problem",
            "slug": "sequoia-pitch-problem",
            "status": "active",
            "canonId": "019dd9b8-1ed4-767b-8e05-40e733bd2311",
            "version": 1,
            "description": null
          },
          "evidence": "The problem statement is clearly presented on page 9, highlighting the need for novel therapies in brain health.",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Complication",
            "slug": "complication",
            "status": "active",
            "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
            "version": 1,
            "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 10,
          "from": 9,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "6e258645-fc1b-4e40-b71b-ce1ca3ac87d4",
          "evidence": "The problem statement and solution sections create a loop that emphasizes the cost of inaction and the potential benefits of MM120.",
          "position": 0,
          "objective": "Highlighting the need for novel therapies",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 22:45:42.011832+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        },
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 10,
      "type": "resolution",
      "title": "Uses a process-flow diagram to illustrate biological mechanism.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 26,
        "componentCount": 3,
        "textChars": 308,
        "nDataPoints": 0,
        "notes": "Uses a process-flow diagram to illustrate biological mechanism.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:54.206+00",
          "seconds": 2.742,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/10",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-10",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.65,
            "w": 0.75,
            "x": 0.13,
            "y": 0.17
          },
          "kind": "diagram",
          "text": "Mechanism of action flow from receptor activation to brain connectivity changes",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:54.206+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "efc3c8a4-8fca-4038-ab52-986ec9d7e494",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.3,
            "x": 0.608,
            "y": 0.535
          },
          "kind": "list",
          "text": "Transiently and powerfully alters perception, behavior, and mood; Intensifies thoughts, emotions, and sensorium; Durable anxiolytic effects and neurogenesis; Decreased rumination, anxiety",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:54.206+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b81fbba9-208e-4c20-a4dd-bae9b084055c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.045,
            "w": 0.41,
            "x": 0.038,
            "y": 0.045
          },
          "kind": "title",
          "text": "Clinical Rationale and Mechanism of Action",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:54.206+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1ae93c87-7af2-474e-8a44-15ba10465014",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "8938da90-d17a-43b8-93c4-f073b05499c6",
          "evidence": "Shows the sequence from drug binding to receptor to clinical outcome",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 10:50:54.206+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 10,
          "frameworkName": "causal-chain"
        }
      ],
      "arcBeats": [
        {
          "to": 10,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 10,
          "name": "Solution",
          "beatId": "ad646e98-f9da-4aac-992e-c74090d46632",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": {
            "name": "Solution",
            "slug": "sequoia-pitch-solution",
            "status": "active",
            "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f",
            "version": 1,
            "description": null
          },
          "evidence": "The solution is presented on page 10, outlining the clinical rationale and mechanism of action for MM120.",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 10,
          "from": 9,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "6e258645-fc1b-4e40-b71b-ce1ca3ac87d4",
          "evidence": "The problem statement and solution sections create a loop that emphasizes the cost of inaction and the potential benefits of MM120.",
          "position": 0,
          "objective": "Highlighting the need for novel therapies",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 22:45:42.011832+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        },
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 11,
      "type": "resolution",
      "title": "Shows specific trial names (Voyage, Panorama, Emerge), sample sizes, randomization, and study phases.",
      "function": "plan_implementation",
      "rawType": "appendix_methodology",
      "block": null,
      "metadata": {
        "slideType": "appendix_methodology",
        "slideTypeCanon": {
          "name": "Appendix methodology",
          "slug": "appendix_methodology",
          "status": "active",
          "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 45,
        "componentCount": 4,
        "textChars": 404,
        "nDataPoints": 3,
        "notes": "Shows specific trial names (Voyage, Panorama, Emerge), sample sizes, randomization, and study phases.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:53.97+00",
          "seconds": 2.386,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/11",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-11",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.12,
            "w": 0.7,
            "x": 0.15,
            "y": 0.1
          },
          "kind": "callout",
          "text": "Aligned clinical trial designs across indications maximize operational efficiencies",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.97+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ccb35cdf-b950-4704-80d1-c3212b593bc7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.65,
            "x": 0.17,
            "y": 0.9
          },
          "kind": "disclaimer",
          "text": "1. Studies will employ an adaptive design... 2. Clinical study designs... 3. Expected first patient dosing. DB: double blind; ODT: orally disintegrating tablet; OL: open-label; RCT: randomized controlled trial",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.97+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "321437c0-2cd5-4343-b29e-a298476056a9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.9,
            "x": 0.05,
            "y": 0.25
          },
          "kind": "list",
          "text": "Generalized Anxiety Disorder (GAD) vs Major Depressive Disorder (MDD) trial structures",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Comparison list",
              "slug": "comparison",
              "status": "active",
              "canonId": "019de52c-fce7-733e-99d3-030a104727bf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "comparison",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.97+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1b4ecea7-7844-4d9e-857c-e6378dc29176",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.4,
            "x": 0.035,
            "y": 0.035
          },
          "kind": "title",
          "text": "MM120 ODT Program Overview",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:53.97+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "155a05cb-dda6-476d-a898-2849b04ffc05",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 12,
      "type": "setup",
      "title": "The slide uses a structured list format to map specific clinical challenges to mitigation strategies.",
      "function": "present_framework",
      "rawType": "appendix_methodology",
      "block": null,
      "metadata": {
        "slideType": "appendix_methodology",
        "slideTypeCanon": {
          "name": "Appendix methodology",
          "slug": "appendix_methodology",
          "status": "active",
          "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7",
          "version": 1,
          "description": null
        },
        "function": "present_framework",
        "functionCanon": {
          "name": "Present framework",
          "slug": "present_framework",
          "status": "active",
          "canonId": "019de52d-1403-7667-9100-d2ac6709f750",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 57,
        "componentCount": 5,
        "textChars": 692,
        "nDataPoints": 0,
        "notes": "The slide uses a structured list format to map specific clinical challenges to mitigation strategies.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:57.251+00",
          "seconds": 5.503,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/12",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-12",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.17,
            "y": 0.94
          },
          "kind": "disclaimer",
          "text": "AE: adverse event; ECG: electrocardiogram; MOA: mechanism of action; TQT: thorough QT",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.251+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "48ea5aa2-dd8c-480c-b282-fe1c8f37f9e1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.7,
            "x": 0.22,
            "y": 0.73
          },
          "kind": "list",
          "text": "Collection of all AEs, including “positive” and MOA-related; Frequent assessment to define time course for resolution of drug effects",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.251+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2ebd466a-71ed-4683-9d87-aab6645ccb3f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.7,
            "x": 0.22,
            "y": 0.16
          },
          "kind": "list",
          "text": "Blinded centralized raters for primary outcome measure; Dose-response in Phase 2 across 'functionally active' doses; Complementary studies with multiple 'functionally masking' arms; Pre- and post-dose expectancy questionnaire; Post-dose blinding questionnaire; Drug effect isolated from psychotherapeutic intervention",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.251+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7f436271-e9ab-4750-85de-771521fceeb3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.7,
            "x": 0.22,
            "y": 0.55
          },
          "kind": "list",
          "text": "Collection of ECGs in Phase 3 Clinical Trials; Dedicated TQT study in parallel with Phase 3",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.251+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c313522c-355c-47f4-8ee9-682616d9403a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.8,
            "x": 0.03,
            "y": 0.04
          },
          "kind": "title",
          "text": "Strategies to Address Key Drug Class Methodological Considerations",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.251+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0f9f6c5d-c284-4363-a1de-fe24764d3c72",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 13,
      "type": "setup",
      "title": "The slide uses a timeline framework to illustrate the stacking of IP protections over time.",
      "function": "present_solution",
      "rawType": "unfair_advantage",
      "block": null,
      "metadata": {
        "slideType": "unfair_advantage",
        "slideTypeCanon": {
          "name": "Unfair advantage",
          "slug": "unfair_advantage",
          "status": "active",
          "canonId": "019de52d-0f56-744f-8bb4-c8a8cca240d6",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 45,
        "componentCount": 4,
        "textChars": 417,
        "nDataPoints": 1,
        "notes": "The slide uses a timeline framework to illustrate the stacking of IP protections over time.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:55.47+00",
          "seconds": 3.615,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/13",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-13",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.62,
            "w": 0.81,
            "x": 0.16,
            "y": 0.12
          },
          "kind": "diagram",
          "text": "Timeline of regulatory and patent protection from launch to 2043+",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Timeline",
              "slug": "timeline",
              "status": "active",
              "canonId": "019de52d-03c5-73fc-84aa-4180cbf0f5cf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "timeline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.47+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "878bdecc-f683-40a0-ab79-26c48c9780ba",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.78,
            "x": 0.16,
            "y": 0.66
          },
          "kind": "list",
          "text": "Supply chain availability, Exclusive rights to key technology, Lifecycle management, Trade secrets & know-how, Differentiated product performance, Differentiated combination",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.47+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "75b3ec44-8442-43c8-81fa-35867481dc4e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.45,
            "x": 0.16,
            "y": 0.93
          },
          "kind": "source-note",
          "text": "1. Section 505 of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 355. PK: pharmacokinetic; PD: pharmacodynamic",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.47+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5d702a1a-d034-472d-b739-903355d63440",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.78,
            "x": 0.03,
            "y": 0.04
          },
          "kind": "title",
          "text": "MM120 | Multiple Layers of Intellectual Property and Protection",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.47+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b31f67f4-346a-4a27-a94a-ca08777bb650",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "List presentation",
            "slug": "list-presentation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
            "version": 1,
            "bodyDocId": null,
            "description": "Bulleted, numbered, or checklist enumerations.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "81ad838e-d0ea-4fa2-9661-6ff5b4a07efe",
          "evidence": "list/bullet: Supply chain availability, Exclusive rights to key technology, Lifecycle management, Trade secrets & know-how, Differentiated product performance, Differentiated combination",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:59:11.564753+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 13,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "6e6c0802-bed8-437a-b673-ae94acc7007f",
          "evidence": "The slide uses a horizontal timeline to show protection duration.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 10:50:55.47+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 13,
          "frameworkName": "timeline"
        }
      ],
      "arcBeats": [],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 14,
      "type": "setup",
      "function": "front_matter",
      "rawType": "cover",
      "block": null,
      "metadata": {
        "slideType": "cover",
        "slideTypeCanon": {
          "name": "Cover",
          "slug": "cover",
          "status": "active",
          "canonId": "019de52d-05f2-729d-9f93-e0504f0a2410",
          "version": 1,
          "description": null
        },
        "function": "front_matter",
        "functionCanon": {
          "name": "Front matter",
          "slug": "front_matter",
          "status": "active",
          "canonId": "019de52d-133d-73f0-9e26-201eda96b098",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 11,
        "componentCount": 3,
        "textChars": 59,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:54.075+00",
          "seconds": 2.169,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/14",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-14",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.074,
            "w": 0.298,
            "x": 0.627,
            "y": 0.232
          },
          "kind": "image",
          "text": "MindMed",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:54.075+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0119a3a3-c377-4c4f-8a9f-6643e18863a3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.074,
            "w": 0.3,
            "x": 0.627,
            "y": 0.598
          },
          "kind": "title",
          "text": "MM120 ODT Lysergide D-tartrate",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:54.075+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e4c94591-6182-4adc-9c04-e988fcb43a09",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.254,
            "x": 0.65,
            "y": 0.765
          },
          "kind": "title",
          "text": "Phase 3 Program in GAD",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:54.075+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "48c47ea2-06d5-4114-a2c7-6625284c6cae",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Slide recipe: Cover",
            "slug": "cover-slide",
            "status": "active",
            "bestFor": null,
            "canonId": "019df269-2a08-767d-9128-e7431e6fe8a3",
            "version": 1,
            "bodyDocId": "019df269-29e5-7738-b5fa-6892e5dc8e65",
            "description": "The first ten seconds. Build it deliberately.",
            "familyLabel": "slide-recipe",
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "designer",
          "layer": "slide",
          "agents": [
            "designer"
          ],
          "matchId": "ac1e5acc-a849-4398-aa63-a519fbbb2b68",
          "evidence": "title/headline: MM120 ODT Lysergide D-tartrate",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 03:59:11.637974+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 14,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 15,
      "type": "resolution",
      "title": "The slide outlines the clinical development strategy for a drug candidate, emphasizing continuity from Phase 2b to Phase 3.",
      "function": "plan_implementation",
      "rawType": "roadmap",
      "block": null,
      "metadata": {
        "slideType": "roadmap",
        "slideTypeCanon": {
          "name": "Roadmap",
          "slug": "roadmap",
          "status": "active",
          "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 60,
        "componentCount": 5,
        "textChars": 912,
        "nDataPoints": 0,
        "notes": "The slide outlines the clinical development strategy for a drug candidate, emphasizing continuity from Phase 2b to Phase 3.",
        "elementsJson": null,
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:54.729+00",
          "seconds": 2.715,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/15",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-15",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.3,
            "w": 0.75,
            "x": 0.21,
            "y": 0.35
          },
          "kind": "list",
          "text": "Key design elements largely consistent between Phase 2b and Phase 3 studies; Hamilton Anxiety Scale (HAM-A) primary outcome measure; Limited changes to key inclusion/exclusion criteria; Duration of treatment session monitoring reduced",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:54.729+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0fe4d321-1040-4c80-b416-93f0306c04c3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.75,
            "x": 0.21,
            "y": 0.15
          },
          "kind": "list",
          "text": "Two Phase 3 pivotal clinical trials in GAD; 12-week randomized, placebo-controlled primary efficacy study design; 40-week extension phase to characterize safety and define retreatment parameters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:54.729+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "54dea5e2-9226-41c1-9e58-2c905eee61cd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.75,
            "x": 0.21,
            "y": 0.68
          },
          "kind": "list",
          "text": "Alignment with FDA on program design reached at EOP2 meeting; Study designs believed to be consistent with FDA guidance; Program initiated December 2024",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:54.729+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6ace2786-567a-407f-b89e-b933760816ca",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.5,
            "x": 0.17,
            "y": 0.92
          },
          "kind": "source-note",
          "text": "1. Clinical study designs subject to ongoing regulatory discussion... 2. Primary endpoint in Phase 2b study was change from baseline to Week 4... 3. Phase 2b study required 12-hour minimum duration of treatment session monitoring... EOP2: end of Phase 2; GAD: generalized anxiety disorder",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:54.729+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b6a80077-04ce-417f-80de-a53e23480bb0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.6,
            "x": 0.04,
            "y": 0.04
          },
          "kind": "title",
          "text": "MM120 ODT for GAD | Phase 3 Program Overview",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:54.729+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "62e2fa0f-17fd-4b06-b613-5e2fa96470c1",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 16,
      "type": "setup",
      "title": "The slide uses a bar chart to compare effect sizes (Cohen's d) across four treatment categories.",
      "function": "compare_peers",
      "rawType": "competitive_analysis",
      "block": null,
      "metadata": {
        "slideType": "competitive_analysis",
        "slideTypeCanon": {
          "name": "Competitive analysis",
          "slug": "competitive_analysis",
          "status": "active",
          "canonId": "019de52d-093e-776b-94c6-c1573f5f1a31",
          "version": 1,
          "description": null
        },
        "function": "compare_peers",
        "functionCanon": {
          "name": "Compare peers",
          "slug": "compare_peers",
          "status": "active",
          "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 54,
        "componentCount": 4,
        "textChars": 649,
        "nDataPoints": 4,
        "notes": "The slide uses a bar chart to compare effect sizes (Cohen's d) across four treatment categories.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:55.407+00",
          "seconds": 3.338,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/16",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-16",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.65,
            "w": 0.52,
            "x": 0.04,
            "y": 0.185
          },
          "kind": "chart",
          "text": "Comparative Effect Sizes in GAD",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Horizontal bar chart",
              "slug": "bar-horizontal",
              "status": "active",
              "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-horizontal",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.407+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5a56c99e-ed09-47bc-ab2d-58aece38ee80",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.94,
            "x": 0.03,
            "y": 0.92
          },
          "kind": "disclaimer",
          "text": "Source: Study MMED008 internal study documents and calculations. Comparisons to standard of care/other drug classes based on historical comparison not head-to-head comparison trial. HAM-A scores based on ANCOVA LS Mean. Based on 100 µg dose group. Source: RB Hidalgo, J Psychopharmacol. 2007 Nov;21(8):864-72.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.407+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9d3ee0d6-d35e-4d20-bd6f-96701d80a1ca",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.35,
            "x": 0.6,
            "y": 0.28
          },
          "kind": "list",
          "text": "Maximum effect size d=0.81 more than double the standard of care; Rapid and durable clinical response after single administration; Clinical activity with no psychotherapeutic intervention beyond study drug",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.407+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0e13b246-70f5-4ff8-b33c-70ab2dea7aaa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.94,
            "x": 0.03,
            "y": 0.05
          },
          "kind": "title",
          "text": "Phase 2 Results in GAD Demonstrated 12-Week Durability with Effect Size Over Double the Standard of Care",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.407+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "93d0895c-4054-4bc1-bc17-93116c6d6957",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Chart Selection Guide",
            "slug": "chart-selection-guide",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
            "version": 1,
            "bodyDocId": null,
            "description": "Choosing the right chart type for your data and message",
            "familyLabel": null,
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "Designer",
          "layer": "slide",
          "agents": [
            "Designer"
          ],
          "matchId": "f88457fe-5006-43a6-b677-c4527347324d",
          "evidence": "chart/bar-horizontal: Comparative Effect Sizes in GAD",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.5,
          "extraction": {
            "at": "2026-07-17 03:59:11.749729+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 16,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "5ef1dcc1-c928-4ee2-88d5-220bcc33152a",
          "evidence": "Direct comparison of effect sizes between proprietary drug and standard of care.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 10:50:55.407+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 16,
          "frameworkName": "comparison_frame"
        }
      ],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 17,
      "type": "evidence",
      "title": "The slide uses a list-based framework to map clinical outcomes to target product profile attributes.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 48,
        "componentCount": 3,
        "textChars": 736,
        "nDataPoints": 3,
        "notes": "The slide uses a list-based framework to map clinical outcomes to target product profile attributes.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:54.93+00",
          "seconds": 2.632,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/17",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-17",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.6,
            "w": 0.9,
            "x": 0.05,
            "y": 0.225
          },
          "kind": "list",
          "text": "Fast Acting: 1.8-point reduction in CGI-S within 24 hours (p<0.0001)\nDurable Activity: 21.9-point improvement in HAM-A at Week 12 (p=0.003)\nResponse / Remission: 48% of participants in remission at Week 12\nLimited Side Effect Burden: Favorable tolerability\nScalability: No additional therapy",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:54.93+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "511a5aa9-f67c-4928-a1c2-56adc5521f91",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.4,
            "x": 0.17,
            "y": 0.92
          },
          "kind": "source-note",
          "text": "1. Source: Study MMED008 internal study documents and calculations. 100 µg dose group. 2. Represents all analyzed secondary endpoints in week 12 topline analysis, including HAM-A, CGI-S and MADRS. 3. p-values not calculated for remission rates between groups. CGI-S: Clinical Global Impressions – Severity; HAM-A: Hamilton Anxiety Scale.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:54.93+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b09aac97-22c0-4da6-b92f-f491be7d4d3b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.94,
            "x": 0.03,
            "y": 0.05
          },
          "kind": "title",
          "text": "Phase 2 Results in GAD Delivered on Target Product Profile after Single Dose and Support Phase 3 Advancement",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:54.93+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6913094d-1fe3-48f2-87e3-765650ccf93e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "f71c9664-7497-4d73-b08f-1bad40ff560d",
          "evidence": "The slide uses a structured list to present key clinical findings against product profile attributes.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 10:50:54.93+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 17,
          "frameworkName": "list-presentation"
        }
      ],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 18,
      "type": "resolution",
      "title": "The slide outlines two distinct study protocols with specific sample sizes and dosing regimens, including a primary endpoint at week 12.",
      "function": "plan_implementation",
      "rawType": "appendix_methodology",
      "block": null,
      "metadata": {
        "slideType": "appendix_methodology",
        "slideTypeCanon": {
          "name": "Appendix methodology",
          "slug": "appendix_methodology",
          "status": "active",
          "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 71,
        "componentCount": 10,
        "textChars": 276,
        "nDataPoints": 6,
        "notes": "The slide outlines two distinct study protocols with specific sample sizes and dosing regimens, including a primary endpoint at week 12.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:56.952+00",
          "seconds": 4.367,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/18",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-18",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.7,
            "w": 0.73,
            "x": 0.235,
            "y": 0.188
          },
          "kind": "diagram",
          "text": "Phase 3 Study Design flow from Part A to Part B",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.952+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0a2b48a8-36a9-4c37-8991-f8f41a74cdd2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.2,
            "x": 0.045,
            "y": 0.615
          },
          "kind": "image",
          "text": "Panorama Study MM120-301",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.952+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7a2c5470-4811-4f67-ab98-9e64717da6a2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.2,
            "x": 0.045,
            "y": 0.335
          },
          "kind": "image",
          "text": "Voyage Study MM120-300",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.952+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a2e6f8c9-fae0-4aff-b3af-b9185106304f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.09,
            "x": 0.235,
            "y": 0.795
          },
          "kind": "metric",
          "text": "N=100",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": null,
            "subkind": {
              "name": "Big number",
              "slug": "big-number",
              "status": "active",
              "canonId": "019de52c-fc70-70c8-b965-0584548a9204",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "big-number",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.952+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "262cad17-e107-47b1-8608-d53758941d60",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.09,
            "x": 0.235,
            "y": 0.615
          },
          "kind": "metric",
          "text": "N=100",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": null,
            "subkind": {
              "name": "Big number",
              "slug": "big-number",
              "status": "active",
              "canonId": "019de52c-fc70-70c8-b965-0584548a9204",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "big-number",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.952+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "39c2036e-e181-4c48-ad28-9eb56f8b7bce",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.09,
            "x": 0.235,
            "y": 0.705
          },
          "kind": "metric",
          "text": "N=40",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": null,
            "subkind": {
              "name": "Big number",
              "slug": "big-number",
              "status": "active",
              "canonId": "019de52c-fc70-70c8-b965-0584548a9204",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "big-number",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.952+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "57c52ffe-f843-40d9-adca-35411044166e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.09,
            "x": 0.235,
            "y": 0.335
          },
          "kind": "metric",
          "text": "N=100",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": null,
            "subkind": {
              "name": "Big number",
              "slug": "big-number",
              "status": "active",
              "canonId": "019de52c-fc70-70c8-b965-0584548a9204",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "big-number",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.952+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "804d5888-d222-4f78-bfd0-c81999077a21",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.09,
            "x": 0.235,
            "y": 0.425
          },
          "kind": "metric",
          "text": "N=100",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": null,
            "subkind": {
              "name": "Big number",
              "slug": "big-number",
              "status": "active",
              "canonId": "019de52c-fc70-70c8-b965-0584548a9204",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "big-number",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.952+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c1e4ea4b-3209-46aa-9f98-aa211bf56ddb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.7,
            "x": 0.168,
            "y": 0.925
          },
          "kind": "source-note",
          "text": "1. Studies will employ an adaptive design with interim blinded sample size re-estimation based on nuisance parameters.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.952+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6cc420f1-e5e7-424e-9f21-616dab02b224",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.045,
            "w": 0.563,
            "x": 0.038,
            "y": 0.048
          },
          "kind": "title",
          "text": "MM120 ODT for GAD | Phase 3 Study Designs",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.952+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "824a53a3-e267-4e3a-8c25-dafe6beb67d7",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "50165c70-be92-4973-bed8-aed6411e1188",
          "evidence": "Visual flow of clinical trial phases",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 10:50:56.952+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 18,
          "frameworkName": "process"
        }
      ],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 19,
      "type": "setup",
      "title": "Includes study timeline, randomization, entry criteria, and endpoints.",
      "function": "present_framework",
      "rawType": "appendix_methodology",
      "block": null,
      "metadata": {
        "slideType": "appendix_methodology",
        "slideTypeCanon": {
          "name": "Appendix methodology",
          "slug": "appendix_methodology",
          "status": "active",
          "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7",
          "version": 1,
          "description": null
        },
        "function": "present_framework",
        "functionCanon": {
          "name": "Present framework",
          "slug": "present_framework",
          "status": "active",
          "canonId": "019de52d-1403-7667-9100-d2ac6709f750",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 63,
        "componentCount": 6,
        "textChars": 403,
        "nDataPoints": 6,
        "notes": "Includes study timeline, randomization, entry criteria, and endpoints.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:59.343+00",
          "seconds": 6.476,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/19",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-19",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.45,
            "w": 0.6,
            "x": 0.05,
            "y": 0.45
          },
          "kind": "diagram",
          "text": "Randomization into Voyage and Panorama study arms",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:59.343+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3d03a7a5-1f83-4b50-9a7f-76209d9b848a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.55,
            "x": 0.05,
            "y": 0.25
          },
          "kind": "diagram",
          "text": "Study timeline from screening to week 12 follow-up",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Timeline",
              "slug": "timeline",
              "status": "active",
              "canonId": "019de52d-03c5-73fc-84aa-4180cbf0f5cf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "timeline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:59.343+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "feaaed25-88d0-4542-8787-227638b979b5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.3,
            "x": 0.65,
            "y": 0.4
          },
          "kind": "list",
          "text": "Entry criteria: Men and Women, Ages 18-74, Diagnosis of GAD, HAM-A >= 20",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:59.343+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "42caac24-8d00-4d21-861c-9d893cc60c91",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.3,
            "x": 0.65,
            "y": 0.6
          },
          "kind": "list",
          "text": "Secondary endpoints: HAM-A at Week 1, CGI-S at Day 2, Time to retreatment / inefficacy",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:59.343+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9ad24497-8760-4c34-be8c-7bf720cec16b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.6,
            "x": 0.05,
            "y": 0.9
          },
          "kind": "source-note",
          "text": "Source: Study MM120-300 and Study MM120-301 internal study documents.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:59.343+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "118842f0-0431-4440-a194-c50e747ff796",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.6,
            "x": 0.03,
            "y": 0.05
          },
          "kind": "title",
          "text": "Phase 3 GAD Part A Schematics: Two Pivotal Studies with Complementary Designs",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:59.343+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "08a24de7-b849-4c2b-bda0-7fa917e2e1ab",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "8b6902b9-4dcd-469a-9c5d-3dcc602e20eb",
          "evidence": "Timeline visualization of clinical trial phases",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 10:50:59.343+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 19,
          "frameworkName": "gantt-chart"
        }
      ],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 20,
      "type": "resolution",
      "title": "Shows a process flow between follow-up observation and potential treatment based on clinical criteria.",
      "function": "plan_implementation",
      "rawType": "appendix_methodology",
      "block": null,
      "metadata": {
        "slideType": "appendix_methodology",
        "slideTypeCanon": {
          "name": "Appendix methodology",
          "slug": "appendix_methodology",
          "status": "active",
          "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 37,
        "componentCount": 4,
        "textChars": 357,
        "nDataPoints": 0,
        "notes": "Shows a process flow between follow-up observation and potential treatment based on clinical criteria.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:59.207+00",
          "seconds": 6.293,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/20",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-20",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.515,
            "w": 0.637,
            "x": 0.046,
            "y": 0.356
          },
          "kind": "diagram",
          "text": "Follow-up Observation and Potential Treatment flow",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:59.207+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1f96e127-5f52-48a0-9b3e-fc464c9a3284",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.25,
            "x": 0.687,
            "y": 0.443
          },
          "kind": "list",
          "text": "Safety of repeated treatment; Time to retreatment / inefficacy; Average treatments/year; Response to retreatment",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:59.207+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "86839b55-0fc5-4a81-a031-8099e0a76d49",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.168,
            "y": 0.935
          },
          "kind": "source-note",
          "text": "Source: Study MM120-300 and MM120-301 study documents. µg: microgram; ePRO: electronic patient reported outcome; HAM-A: Hamilton Anxiety Rating Scale",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:59.207+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b2758b3b-626a-4691-902a-b9a7803128fd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.038,
            "w": 0.596,
            "x": 0.038,
            "y": 0.048
          },
          "kind": "title",
          "text": "Phase 3 GAD Part B Schematics: Extension Phase",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:59.207+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "46bdcb8c-7050-45b8-a9dc-ae32220d748e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "ed723333-e77e-4f21-bf46-ca998e71341a",
          "evidence": "Flowchart showing clinical trial phases and decision criteria",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 10:50:59.207+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 20,
          "frameworkName": "process"
        }
      ],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 21,
      "type": "analysis",
      "title": "Includes logos for Voyage and Panorama studies; references statistical power assumptions in footnotes.",
      "function": "analyze_data",
      "rawType": "appendix_data",
      "block": null,
      "metadata": {
        "slideType": "appendix_data",
        "slideTypeCanon": {
          "name": "Appendix data",
          "slug": "appendix_data",
          "status": "active",
          "canonId": "019de52d-078a-745b-9ee4-c15f2f539acd",
          "version": 1,
          "description": null
        },
        "function": "analyze_data",
        "functionCanon": {
          "name": "Analyze data",
          "slug": "analyze_data",
          "status": "active",
          "canonId": "019de52d-1590-7413-8c82-cc218cff40b4",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 48,
        "componentCount": 4,
        "textChars": 474,
        "nDataPoints": 3,
        "notes": "Includes logos for Voyage and Panorama studies; references statistical power assumptions in footnotes.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:59.991+00",
          "seconds": 6.97,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/21",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-21",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.4,
            "w": 0.35,
            "x": 0.62,
            "y": 0.26
          },
          "kind": "callout",
          "text": "Phase 2b HAM-A Results at Week 12: -21.9 points from Baseline, -7.7 points vs. placebo (p=0.003). Phase 3 studies have 90% power to detect a 5.0-point difference vs. placebo.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:59.991+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c6455aee-8c98-4d30-8fa6-607e34dba29b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.5,
            "x": 0.04,
            "y": 0.28
          },
          "kind": "diagram",
          "text": "Primary and Key Secondaries list",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:59.991+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1377e586-96d7-400d-a50b-f348f04f4fdd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.55,
            "x": 0.17,
            "y": 0.9
          },
          "kind": "disclaimer",
          "text": "1. Clinical study designs subject to ongoing regulatory discussion and review, including of Phase 3 clinical trial protocols. 2. 100 µg dose group. 3. Based on assumption of n=85 evaluable subjects per arm...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:59.991+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "09c66064-44d1-4797-bfbe-acaad92db819",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.75,
            "x": 0.038,
            "y": 0.045
          },
          "kind": "title",
          "text": "Phase 3 GAD Part A Trials: Primary & Key Secondary Endpoints",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:59.991+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "28538f40-5574-43ab-b3cb-2f75aa888889",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 22,
      "type": "setup",
      "function": "front_matter",
      "rawType": "cover",
      "block": null,
      "metadata": {
        "slideType": "cover",
        "slideTypeCanon": {
          "name": "Cover",
          "slug": "cover",
          "status": "active",
          "canonId": "019de52d-05f2-729d-9f93-e0504f0a2410",
          "version": 1,
          "description": null
        },
        "function": "front_matter",
        "functionCanon": {
          "name": "Front matter",
          "slug": "front_matter",
          "status": "active",
          "canonId": "019de52d-133d-73f0-9e26-201eda96b098",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 11,
        "componentCount": 3,
        "textChars": 59,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:55.413+00",
          "seconds": 2.263,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/22",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-22",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.074,
            "w": 0.298,
            "x": 0.627,
            "y": 0.232
          },
          "kind": "image",
          "text": "MindMed",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.413+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4334c8f3-58c9-4a66-9646-aa87a63248d4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.074,
            "w": 0.298,
            "x": 0.627,
            "y": 0.598
          },
          "kind": "title",
          "text": "MM120 ODT Lysergide D-tartrate",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.413+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ee0949c8-c1fe-4dc2-a451-53fd598bbce0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.028,
            "w": 0.256,
            "x": 0.648,
            "y": 0.763
          },
          "kind": "title",
          "text": "Phase 3 Program in MDD",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.413+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5d9857c7-92fb-4547-9609-a371c4161da4",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 23,
      "type": "evidence",
      "title": "The slide uses a table to establish scientific credibility for the company's therapeutic focus.",
      "function": "cite_precedent",
      "rawType": "appendix_data",
      "block": null,
      "metadata": {
        "slideType": "appendix_data",
        "slideTypeCanon": {
          "name": "Appendix data",
          "slug": "appendix_data",
          "status": "active",
          "canonId": "019de52d-078a-745b-9ee4-c15f2f539acd",
          "version": 1,
          "description": null
        },
        "function": "cite_precedent",
        "functionCanon": {
          "name": "Cite precedent",
          "slug": "cite_precedent",
          "status": "active",
          "canonId": "019de52d-142b-714b-86d4-58aad7b568ec",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 59,
        "componentCount": 4,
        "textChars": 1035,
        "nDataPoints": 4,
        "notes": "The slide uses a table to establish scientific credibility for the company's therapeutic focus.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:56.017+00",
          "seconds": 2.856,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/23",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-23",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.55,
            "x": 0.16,
            "y": 0.91
          },
          "kind": "disclaimer",
          "text": "1. Rucker JJ, Jelen LA, Flynn S, Frowde KD, Young AH. Psychedelics in the treatment of unipolar mood disorders: a systematic review. J Psychopharmacol. 2016;30(12):1220-1229. 2. Gasser P, Holstein D, Michel Y, Doblin R, Yazar-Klosinski B, Passie T, Brenneisen R. Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis. 2014 Jul;202(7):513-20. 3. Holze F, Gasser P, Müller F, Dolder PC, Liechti ME. Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study. Biol Psychiatry. 2023 Feb 1;93(3):215-223. 4. Muller F. 2023, April 18. A Study on the Efficacy and Safety of LSD in Depressive Disorders [Conference presentation]. Basel, Switzerland. NCT03866252.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.017+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "52a67c0a-20bf-4290-8552-490ce62e22f2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.9,
            "w": 0.42,
            "x": 0.58,
            "y": 0.14
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.017+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "061f1607-33c7-4248-86e8-742d82683cf2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.65,
            "x": 0.03,
            "y": 0.208
          },
          "kind": "table",
          "text": "Studies, Indication(s), Sample Size, Key Findings. 21 Studies prior to 1974, Gasser 2014, Holze 2023, Muller 2023.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.017+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "19f9a28e-efd0-40e5-9ea5-3825fe032336",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.75,
            "x": 0.03,
            "y": 0.04
          },
          "kind": "title",
          "text": "Decades of Clinical Research Supports LSD’s Unique Potential",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.017+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b690f5f5-a90f-4c6b-a3ab-e6c87a6c6f9a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "ccf62092-bea6-4c54-9c5c-f2d06be0deff",
          "evidence": "Citing specific clinical studies to validate the therapeutic potential of the product.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 10:50:56.017+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 23,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 24,
      "type": "evidence",
      "title": "The chart displays LS Mean Change from baseline across multiple dose groups (25, 50, 100, 200 ug) versus placebo.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 48,
        "componentCount": 4,
        "textChars": 449,
        "nDataPoints": 4,
        "notes": "The chart displays LS Mean Change from baseline across multiple dose groups (25, 50, 100, 200 ug) versus placebo.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:55.896+00",
          "seconds": 2.533,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/24",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-24",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.6,
            "w": 0.65,
            "x": 0.05,
            "y": 0.25
          },
          "kind": "chart",
          "text": "MADRS Change from Baseline",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.896+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "346cb10f-e899-4f14-9fad-12c0fbaa795b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.25,
            "x": 0.72,
            "y": 0.3
          },
          "kind": "list",
          "text": "Change from Baseline: Week 4: -18.1 points, Week 12: -18.7 points. Improvement over Placebo: Week 4: -5.7 points, p<0.05, Week 12: -6.4 points, p<0.01",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.896+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0aeffeb2-a52a-4272-b8ee-1646c42b5818",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.6,
            "x": 0.05,
            "y": 0.9
          },
          "kind": "source-note",
          "text": "1. Source: MindMed internal study documents and calculations. 2. Based on 100 ug dose group. 3. Significance achieved despite study not being powered for these pairwise comparisons.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.896+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "615ddc5e-7843-4aa3-aee3-1567fe0a607c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "MM120 Antidepressant Potential Demonstrated in GAD Patients with Comorbid Depression (MADRS)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:55.896+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "eebe9b4b-0872-4a2c-bbb6-05b8101f52d5",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Waterfall chart",
            "slug": "waterfall-chart",
            "status": "active",
            "bestFor": null,
            "canonId": "e2799da3-725f-44a9-a093-570f1f388e64",
            "version": 1,
            "bodyDocId": null,
            "description": null,
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "a8662c2b-8b6c-4fdb-9662-9d32956261a5",
          "evidence": "chart/line: MADRS Change from Baseline",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 00:49:26.147726+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 24,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 25,
      "type": "resolution",
      "title": "The slide outlines a clinical trial protocol with a primary endpoint at week 6 and a 40-week extension phase.",
      "function": "plan_implementation",
      "rawType": "appendix_methodology",
      "block": null,
      "metadata": {
        "slideType": "appendix_methodology",
        "slideTypeCanon": {
          "name": "Appendix methodology",
          "slug": "appendix_methodology",
          "status": "active",
          "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 50,
        "componentCount": 5,
        "textChars": 328,
        "nDataPoints": 4,
        "notes": "The slide outlines a clinical trial protocol with a primary endpoint at week 6 and a 40-week extension phase.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:56.974+00",
          "seconds": 3.416,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/25",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-25",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.23,
            "w": 0.718,
            "x": 0.232,
            "y": 0.152
          },
          "kind": "diagram",
          "text": "Part A: 12 Week Randomized, Double-Blind; Part B: 40 Week Extension with Opportunity for Open-Label Treatment",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.974+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "84e04df6-2b46-43c0-a590-5fbae901f75f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.12,
            "x": 0.292,
            "y": 0.498
          },
          "kind": "legend",
          "text": "Primary Endpoint (MADRS at Week 6)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Legend",
              "slug": "legend",
              "status": "active",
              "canonId": "31361933-3d22-4c70-bbad-0801e9fffc0c",
              "version": 1,
              "description": "Color/symbol decoder placed adjacent to a chart or diagram."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.974+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3184bcd8-bfde-4121-b3e6-e8a9f9d0b456",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.1,
            "x": 0.089,
            "y": 0.458
          },
          "kind": "paragraph",
          "text": "MM120-310; MM120-311",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.974+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fdc3f72f-5e71-4448-82a8-cfabd451598c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.012,
            "w": 0.538,
            "x": 0.168,
            "y": 0.942
          },
          "kind": "source-note",
          "text": "1. Clinical study designs subject to ongoing regulatory discussion and review, including of Phase 3 clinical trial protocols.",
          "attrs": {
            "numbered": true
          },
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.974+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "608fccb2-0a71-49e2-9983-d265f94a50e2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.035,
            "w": 0.43,
            "x": 0.038,
            "y": 0.048
          },
          "kind": "title",
          "text": "MM120 ODT for MDD | Phase 3 Study Design",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.974+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0782129d-1202-4d0b-b2f2-535e7c8f4076",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "cf892d25-f425-4339-8241-332e5c4894b2",
          "evidence": "The slide maps out the phases, arms, and endpoints of a clinical study.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 10:50:56.974+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 25,
          "frameworkName": "clinical-trial-design"
        }
      ],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 26,
      "type": "resolution",
      "title": "Includes study timeline, randomization details, entry criteria, and secondary endpoints.",
      "function": "plan_implementation",
      "rawType": "appendix_methodology",
      "block": null,
      "metadata": {
        "slideType": "appendix_methodology",
        "slideTypeCanon": {
          "name": "Appendix methodology",
          "slug": "appendix_methodology",
          "status": "active",
          "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 55,
        "componentCount": 5,
        "textChars": 439,
        "nDataPoints": 2,
        "notes": "Includes study timeline, randomization details, entry criteria, and secondary endpoints.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:56.28+00",
          "seconds": 2.72,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/26",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-26",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.25,
            "w": 0.5,
            "x": 0.09,
            "y": 0.25
          },
          "kind": "diagram",
          "text": "Study timeline showing screening, dosing, and follow-up weeks",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Timeline",
              "slug": "timeline",
              "status": "active",
              "canonId": "019de52d-03c5-73fc-84aa-4180cbf0f5cf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "timeline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.28+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7fba8aa5-5bfa-49a4-9252-c2df55b08fca",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.25,
            "x": 0.66,
            "y": 0.395
          },
          "kind": "list",
          "text": "Key Entry Criteria: Men and Women, Ages 18-74, Diagnosis of MDD, MADRS >= 26",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.28+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "15771ffd-2cc0-47b1-b5ae-759654e86fbe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.25,
            "x": 0.66,
            "y": 0.6
          },
          "kind": "list",
          "text": "Secondary Endpoints: MADRS at Week 12, MADRS at Week 1, CGI-S at Day 2, Time to retreatment / inefficacy",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.28+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d907885d-51ed-4fc5-816a-abb5600f330e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.55,
            "x": 0.17,
            "y": 0.92
          },
          "kind": "source-note",
          "text": "Source: Study MM120-310 study documents. Clinical study designs subject to ongoing regulatory discussion and review, including of Phase 3 clinical protocols.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.28+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "42a835c2-2a5a-4bd3-9f05-1b6d2121646c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.42,
            "x": 0.038,
            "y": 0.048
          },
          "kind": "title",
          "text": "Phase 3 MDD Trial Schematic: Emerge Study",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.28+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "30bd72d5-2bca-40b4-b748-69fe03502df4",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "010d6518-3fd7-4936-8cbf-d37806228092",
          "evidence": "Visual timeline of clinical trial phases",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 10:50:56.28+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 26,
          "frameworkName": "gantt-chart"
        }
      ],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 27,
      "type": "setup",
      "title": "The slide features the MindMed logo and the specific drug candidate and trial phase.",
      "function": "front_matter",
      "rawType": "cover",
      "block": null,
      "metadata": {
        "slideType": "cover",
        "slideTypeCanon": {
          "name": "Cover",
          "slug": "cover",
          "status": "active",
          "canonId": "019de52d-05f2-729d-9f93-e0504f0a2410",
          "version": 1,
          "description": null
        },
        "function": "front_matter",
        "functionCanon": {
          "name": "Front matter",
          "slug": "front_matter",
          "status": "active",
          "canonId": "019de52d-133d-73f0-9e26-201eda96b098",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 11,
        "componentCount": 3,
        "textChars": 60,
        "nDataPoints": 0,
        "notes": "The slide features the MindMed logo and the specific drug candidate and trial phase.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:56.008+00",
          "seconds": 2.341,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/27",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-27",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.1,
            "w": 0.3,
            "x": 0.625,
            "y": 0.23
          },
          "kind": "image",
          "text": "MindMed",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.008+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3fb86995-d257-4616-a6e0-e148f5900254",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.3,
            "x": 0.625,
            "y": 0.58
          },
          "kind": "title",
          "text": "MM120 ODT Lysergide D-tartrate",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.008+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c0b343e7-1185-4b8c-bbf6-c844963d6634",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.3,
            "x": 0.625,
            "y": 0.75
          },
          "kind": "title",
          "text": "Phase 2b Results in GAD",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.008+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d78e7e2c-d334-4ed2-a77e-b3e7b4dc6bcc",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 28,
      "type": "resolution",
      "title": "The slide emphasizes regulatory alignment and standard clinical trial methodology.",
      "function": "plan_implementation",
      "rawType": "appendix_methodology",
      "block": null,
      "metadata": {
        "slideType": "appendix_methodology",
        "slideTypeCanon": {
          "name": "Appendix methodology",
          "slug": "appendix_methodology",
          "status": "active",
          "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 57,
        "componentCount": 4,
        "textChars": 892,
        "nDataPoints": 2,
        "notes": "The slide emphasizes regulatory alignment and standard clinical trial methodology.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:56.611+00",
          "seconds": 2.719,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/28",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-28",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.5,
            "w": 0.8,
            "x": 0.08,
            "y": 0.3
          },
          "kind": "list",
          "text": "Single administration of MM120 or placebo\nNo psychotherapeutic intervention\nTrial design closely aligned with subsequently issued FDA 2023 Draft Guidance\nPatients washed out of anxiety pharmacotherapy prior to randomization\nAssessed by central rater blinded to treatment assignment and visit number",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.611+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1c0cb1ed-0053-466a-bccd-5b30e1f915a1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.9,
            "x": 0.05,
            "y": 0.2
          },
          "kind": "list",
          "text": "Standard GAD study design with endpoints that have supported registration for approved drugs\nRandomized, double-blind, placebo-controlled, 12-week trial\nEnrolled 198 patients with GAD\nFive-arm dose optimization design with 1:1:1:1:1 randomization\nPrimary endpoint: change in Hamilton Anxiety Scale (HAM-A) at week 4",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.611+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fbd1e818-eabc-43f0-b986-3749ed4801eb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.5,
            "x": 0.05,
            "y": 0.92
          },
          "kind": "source-note",
          "text": "1. Source: Study MMED008 internal study documents and calculations.\n2. FDA 2023 Draft Guidance: Psychedelic Drugs: Considerations for Clinical Investigations.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.611+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e35af5e1-9b52-4010-b6ff-4ccdd864f0e6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "Phase 2b Trial of MM120 Utilized Standard GAD Design and Endpoints and was Aligned with FDA Draft Guidance for Drug Class",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.611+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "498eb255-c387-4582-968c-c3ad492bbea4",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 29,
      "type": "resolution",
      "title": "Includes study arms, dosing, follow-up timeline, entry criteria, and secondary endpoints.",
      "function": "plan_implementation",
      "rawType": "appendix_methodology",
      "block": null,
      "metadata": {
        "slideType": "appendix_methodology",
        "slideTypeCanon": {
          "name": "Appendix methodology",
          "slug": "appendix_methodology",
          "status": "active",
          "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 42,
        "componentCount": 5,
        "textChars": 303,
        "nDataPoints": 0,
        "notes": "Includes study arms, dosing, follow-up timeline, entry criteria, and secondary endpoints.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:56.952+00",
          "seconds": 2.95,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/29",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-29",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.6,
            "w": 0.55,
            "x": 0.09,
            "y": 0.25
          },
          "kind": "diagram",
          "text": "Trial timeline showing screening, dosing, and follow-up weeks",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Timeline",
              "slug": "timeline",
              "status": "active",
              "canonId": "019de52d-03c5-73fc-84aa-4180cbf0f5cf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "timeline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.952+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d6901127-6b6e-49b1-865b-856791c6b0ee",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.2,
            "x": 0.67,
            "y": 0.6
          },
          "kind": "list",
          "text": "Additional Endpoints: MADRS, CGI-S/I, PGI-S/C, SDS, EQ-5D-5L, PSQI, ASEX",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.952+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "15b11a45-fc4b-41c3-8947-da43fa89ada4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.2,
            "x": 0.67,
            "y": 0.395
          },
          "kind": "list",
          "text": "Key Entry Criteria: Men and Women, Ages 18-74, Diagnosis of GAD, HAM-A >= 20",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.952+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "94c96d8a-e78f-49cc-8eda-a6a65515689d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.55,
            "x": 0.16,
            "y": 0.92
          },
          "kind": "source-note",
          "text": "Source: Study MMED008 internal study documents. Abbreviations defined.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.952+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "baa106ee-e718-43d1-a76f-a52a66edadbb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.32,
            "x": 0.038,
            "y": 0.05
          },
          "kind": "title",
          "text": "Phase 2b Trial Schematic",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.952+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bb371ecc-f621-452e-9ca8-47068db9c1bc",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "d2d78c19-c6f0-4d19-b338-a643f48d7e61",
          "evidence": "Visual timeline of clinical trial phases",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 10:50:56.952+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 29,
          "frameworkName": "gantt-chart"
        }
      ],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 30,
      "type": "setup",
      "title": "Uses a comparison table to define what is and is not part of the patient journey.",
      "function": "present_framework",
      "rawType": "customer_journey",
      "block": null,
      "metadata": {
        "slideType": "customer_journey",
        "slideTypeCanon": {
          "name": "Customer journey",
          "slug": "customer_journey",
          "status": "active",
          "canonId": "019de52d-0966-70ce-afe3-bc7c98ffc8c9",
          "version": 1,
          "description": null
        },
        "function": "present_framework",
        "functionCanon": {
          "name": "Present framework",
          "slug": "present_framework",
          "status": "active",
          "canonId": "019de52d-1403-7667-9100-d2ac6709f750",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 46,
        "componentCount": 4,
        "textChars": 589,
        "nDataPoints": 0,
        "notes": "Uses a comparison table to define what is and is not part of the patient journey.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:56.762+00",
          "seconds": 2.758,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/30",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-30",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.15,
            "w": 0.8,
            "x": 0.037,
            "y": 0.17
          },
          "kind": "paragraph",
          "text": "Dosing session monitors (DSMs) in the room provide no psychotherapeutic intervention\nDelivery protocol consistent with 2023 FDA Draft Guidance\nNo significant changes planned to treatment session delivery between Phase 2 and Phase 3",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.762+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "08640fc8-00e2-4212-84c8-ec018dd6aef1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.4,
            "x": 0.16,
            "y": 0.93
          },
          "kind": "source-note",
          "text": "1. Source: Study MMED008 internal study documents. 2. FDA 2023 Draft Guidance: Psychedelic Drugs: Considerations for Clinical Investigations.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.762+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4fc96f9b-9cc5-43ae-95fc-0d85427c5aea",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.95,
            "x": 0.025,
            "y": 0.38
          },
          "kind": "table",
          "text": "Patient Journey in MMED008 vs Not Part of Patient Journey in MMED008 across Pre-treatment, During treatment, and Post-treatment phases.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.762+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5a914fd5-f618-4167-886a-8fd22e8b207c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.037,
            "y": 0.05
          },
          "kind": "title",
          "text": "Treatment Paradigm: Standalone Drug Effects with No Psychotherapeutic Intervention",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:56.762+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a5209a0d-d412-4c34-bfc0-87ce8bed5fb9",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Customer journey map",
            "slug": "customer-journey-map",
            "status": "active",
            "bestFor": null,
            "canonId": "019de52d-1b26-7499-98c8-1091acc836be",
            "version": 1,
            "bodyDocId": null,
            "description": null,
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "cc0e0309-3c77-481b-9522-386b2c1b49f4",
          "evidence": "Treatment Paradigm: Standalone Drug Effects with No Psychotherapeutic Intervention",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-17 00:49:26.432405+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 30,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "fcafa79e-1bad-40ca-9910-ecdedd5c8ff1",
          "evidence": "The table maps the patient experience across three distinct phases of the clinical trial.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 10:50:56.762+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 30,
          "frameworkName": "customer-journey-map"
        }
      ],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 31,
      "type": "analysis",
      "title": "The slide uses a CONSORT-style flow diagram to track patient retention.",
      "function": "analyze_data",
      "rawType": "appendix_data",
      "block": null,
      "metadata": {
        "slideType": "appendix_data",
        "slideTypeCanon": {
          "name": "Appendix data",
          "slug": "appendix_data",
          "status": "active",
          "canonId": "019de52d-078a-745b-9ee4-c15f2f539acd",
          "version": 1,
          "description": null
        },
        "function": "analyze_data",
        "functionCanon": {
          "name": "Analyze data",
          "slug": "analyze_data",
          "status": "active",
          "canonId": "019de52d-1590-7413-8c82-cc218cff40b4",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 58,
        "componentCount": 5,
        "textChars": 434,
        "nDataPoints": 25,
        "notes": "The slide uses a CONSORT-style flow diagram to track patient retention.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:57.271+00",
          "seconds": 3.213,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/31",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-31",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.75,
            "w": 0.5,
            "x": 0.12,
            "y": 0.15
          },
          "kind": "diagram",
          "text": "Flow diagram showing randomization into 5 groups (200, 100, 50, 25 ug and placebo) with n-counts and outcomes.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.271+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c1ab5f62-55b4-4164-9871-21f2908419d1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.4,
            "x": 0.16,
            "y": 0.92
          },
          "kind": "disclaimer",
          "text": "Source: Study MMED008 internal study documents and calculations. Safety population. High dose groups include 100 and 200 ug dose groups. FAS: Full Analysis Set",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.271+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b7e30106-725a-4996-a76e-414298aa238b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.3,
            "x": 0.64,
            "y": 0.26
          },
          "kind": "metric",
          "text": "79% 12-week completion rate in high dose groups",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": null,
            "subkind": {
              "name": "Big number",
              "slug": "big-number",
              "status": "active",
              "canonId": "019de52c-fc70-70c8-b965-0584548a9204",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "big-number",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.271+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b41089d2-fdad-43c6-8e90-bab1d58d1a00",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.3,
            "x": 0.64,
            "y": 0.56
          },
          "kind": "metric",
          "text": "74% 12-week completion rate of all randomized participants",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": null,
            "subkind": {
              "name": "Big number",
              "slug": "big-number",
              "status": "active",
              "canonId": "019de52c-fc70-70c8-b965-0584548a9204",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "big-number",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.271+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f77a515a-ec26-4e98-961f-966ba4600f1b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.6,
            "x": 0.04,
            "y": 0.05
          },
          "kind": "title",
          "text": "Participant Disposition Aligned with Historical Expectations",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.271+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ef24cf7a-f35f-42df-b0df-566a772dcdc6",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "4428c2a6-94b6-4df4-8959-9a01e06fad4f",
          "evidence": "Standard clinical trial participant disposition reporting structure",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 10:50:57.271+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 31,
          "frameworkName": "CONSORT flow diagram"
        }
      ],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 32,
      "type": "analysis",
      "title": "The table displays mean age, sex distribution, race, and baseline HAM-A and CGI-S scores for n=194 participants.",
      "function": "analyze_data",
      "rawType": "appendix_data",
      "block": null,
      "metadata": {
        "slideType": "appendix_data",
        "slideTypeCanon": {
          "name": "Appendix data",
          "slug": "appendix_data",
          "status": "active",
          "canonId": "019de52d-078a-745b-9ee4-c15f2f539acd",
          "version": 1,
          "description": null
        },
        "function": "analyze_data",
        "functionCanon": {
          "name": "Analyze data",
          "slug": "analyze_data",
          "status": "active",
          "canonId": "019de52d-1590-7413-8c82-cc218cff40b4",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 47,
        "componentCount": 3,
        "textChars": 561,
        "nDataPoints": 25,
        "notes": "The table displays mean age, sex distribution, race, and baseline HAM-A and CGI-S scores for n=194 participants.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:57.879+00",
          "seconds": 3.774,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/32",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-32",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.16,
            "y": 0.94
          },
          "kind": "source-note",
          "text": "1. Source: Study MMED008 internal study documents and calculations. Full analysis set population.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.879+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7cfdd18d-b1a2-4f33-b109-f009e4f804f4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.93,
            "x": 0.033,
            "y": 0.202
          },
          "kind": "table",
          "text": "Demographic (n=194) | 25 ug (n=39) | 50 ug (n=36) | 100 ug (n=40) | 200 ug (n=40) | Placebo (n=39) | Mean age (years) | 38.0 | 45.3 | 42.7 | 42.1 | 38.7 | Sex, female (%) | 51.3% | 55.6% | 40.0% | 70.0% | 66.7% | Race (% white) | 84.6% | 80.6% | 90.0% | 82.5% | 76.9% | Baseline HAM-A score | 30.2 | 30.3 | 29.3 | 31.0 | 30.3 | Baseline CGI-S score | 4.9 | 4.9 | 4.8 | 5.1 | 4.9",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.879+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ae4fb66e-ff0a-4620-8f19-41753fac7b1e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.037,
            "y": 0.05
          },
          "kind": "title",
          "text": "Participant Demographics and Baseline Characteristics Generally Balanced Across Groups",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.879+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f9e1e7d1-dc9f-4ec9-bab8-172fe192bd9c",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 33,
      "type": "evidence",
      "title": "The chart highlights the efficacy of the 100ug dose group specifically in the callout box.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 43,
        "componentCount": 4,
        "textChars": 352,
        "nDataPoints": 4,
        "notes": "The chart highlights the efficacy of the 100ug dose group specifically in the callout box.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:57.483+00",
          "seconds": 3.164,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/33",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-33",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.65,
            "w": 0.65,
            "x": 0.06,
            "y": 0.175
          },
          "kind": "chart",
          "text": "HAM-A Change from Baseline",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.483+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "951f6e0c-68ea-4222-b122-c51023027c7f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.25,
            "x": 0.73,
            "y": 0.25
          },
          "kind": "list",
          "text": "Change from Baseline: Week 4: -21.3 points, Week 12: -21.9 points. Improvement over Placebo: Week 4: -7.6 pts, p=0.0004, Week 12: -7.7 pts, p=0.003",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.483+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "52e8a530-db89-4b27-bee0-a89ec0f1e4fb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.5,
            "x": 0.16,
            "y": 0.92
          },
          "kind": "source-note",
          "text": "Source: Study MMED008 internal study documents and calculations. Based on 100 ug dose group.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.483+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4b1d474a-5ebc-404f-bbbf-41cd6aa4318a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.92,
            "x": 0.04,
            "y": 0.05
          },
          "kind": "title",
          "text": "Statistically and Clinically Significant Reductions in HAM-A Score Continued at Week 12",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.483+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d09c3fb2-01dc-4bcc-8d68-6bb58b52c011",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 34,
      "type": "evidence",
      "title": "Data compares Placebo, 25ug, 50ug, 100ug, and 200ug doses.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 49,
        "componentCount": 4,
        "textChars": 441,
        "nDataPoints": 10,
        "notes": "Data compares Placebo, 25ug, 50ug, 100ug, and 200ug doses.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:58.531+00",
          "seconds": 4.147,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/34",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-34",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.6,
            "w": 0.45,
            "x": 0.55,
            "y": 0.23
          },
          "kind": "chart",
          "text": "HAM-A Remission Rate at Week 12",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:58.531+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9dd4d763-c737-4ed1-84f6-2f826849dadf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.45,
            "x": 0.05,
            "y": 0.23
          },
          "kind": "chart",
          "text": "HAM-A Response Rate at Week 12",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:58.531+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a2c363fd-30df-4c27-b64d-7f7c65121755",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.6,
            "x": 0.05,
            "y": 0.9
          },
          "kind": "source-note",
          "text": "1. Source: Study MMED008 internal study documents and calculations. Full analysis set population. 2. Response is defined as a 50% or greater improvement on HAM-A score; Remission is defined as a HAM-A score of ≤ 7. µg: microgram; HAM-A: Hamilton Anxiety Rating Scale",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:58.531+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9bf6dc33-cd7d-427b-8809-9aaf29f1275b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "Continued Response and Remission through Week 12 with 65% Clinical Responder Rate and 48% Clinical Remission Rate¹",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:58.531+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d2c1349e-e254-4b37-bfaa-cda5385095b6",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 35,
      "type": "analysis",
      "title": "MCP-Mod is a statistical methodology for dose-response modeling.",
      "function": "analyze_data",
      "rawType": "appendix_methodology",
      "block": null,
      "metadata": {
        "slideType": "appendix_methodology",
        "slideTypeCanon": {
          "name": "Appendix methodology",
          "slug": "appendix_methodology",
          "status": "active",
          "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7",
          "version": 1,
          "description": null
        },
        "function": "analyze_data",
        "functionCanon": {
          "name": "Analyze data",
          "slug": "analyze_data",
          "status": "active",
          "canonId": "019de52d-1590-7413-8c82-cc218cff40b4",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 45,
        "componentCount": 4,
        "textChars": 563,
        "nDataPoints": 0,
        "notes": "MCP-Mod is a statistical methodology for dose-response modeling.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:57.631+00",
          "seconds": 3.243,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/35",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-35",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.65,
            "w": 0.43,
            "x": 0.09,
            "y": 0.21
          },
          "kind": "chart",
          "text": "Grid of 6 candidate dose-response curves",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.631+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "491443cd-33b2-4702-b934-15dcaf2686e0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.38,
            "x": 0.57,
            "y": 0.28
          },
          "kind": "list",
          "text": "Statistically significant dose response relationship with multiple model fits. Supports dose selection of 100 µg for subsequent studies in GAD. Pre-specified model estimates and observed responses drive dose selection for Phase 3 studies.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.631+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a961e715-ca7b-40bc-83a2-53a19004166a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.45,
            "x": 0.16,
            "y": 0.93
          },
          "kind": "source-note",
          "text": "1. Source: Study MMED008 internal study documents and calculations. Full analysis set population. 2. Source: Novartis. \"The MCP-Mod methodology – A statistical methodology for dose-response.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.631+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a5c1a720-f679-4e5c-b5aa-cf496c46289a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.03,
            "y": 0.05
          },
          "kind": "title",
          "text": "Primary & Key Secondary Analysis (MCP-Mod) Support Dose Response Relationship for MM120 in GAD",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.631+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7917f403-c179-4b0e-aaae-dbb73e8f0a07",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "76c235bd-8551-4270-af82-c103566bbfbd",
          "evidence": "Explicitly mentioned in title and takeaways as the statistical methodology used.",
          "framework": null,
          "confidence": 1,
          "extraction": {
            "at": "2026-05-02 10:50:57.631+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 35,
          "frameworkName": "MCP-Mod"
        }
      ],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 36,
      "type": "evidence",
      "title": "The chart shows a clear separation between placebo and treatment groups across time points.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 55,
        "componentCount": 4,
        "textChars": 623,
        "nDataPoints": 8,
        "notes": "The chart shows a clear separation between placebo and treatment groups across time points.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:57.532+00",
          "seconds": 2.989,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/36",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-36",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.55,
            "w": 0.45,
            "x": 0.51,
            "y": 0.23
          },
          "kind": "chart",
          "text": "CGI-S Scores at Week 12",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Grouped bar chart",
              "slug": "bar-grouped",
              "status": "active",
              "canonId": "019de52c-ff3b-751e-a8ff-f21ff11097b1",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-grouped",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.532+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4a10fb54-f76a-4ca9-868a-22581b88cef8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.38,
            "x": 0.06,
            "y": 0.25
          },
          "kind": "list",
          "text": "Statistically and clinically significant improvement by Day 2 and maintained through Week 12; Greater than 2-unit improvement in CGI-S score through Week 12; Participants on average only borderline-to-mildly ill at Week 12",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.532+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "05d86eb3-cd69-4bc2-b9d0-e7a97a02fb4c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.45,
            "x": 0.16,
            "y": 0.92
          },
          "kind": "source-note",
          "text": "1. Source: Study MMED008 internal study documents and calculations. Full analysis set population. 2. Significance achieved despite study not being powered for these pairwise comparisons. µg: microgram; CGI-S: Clinical Global Impressions - Severity",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.532+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4a563514-044b-4317-98dd-1e287248d527",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.92,
            "x": 0.04,
            "y": 0.05
          },
          "kind": "title",
          "text": "Rapid and Sustained Improvements in Clinical Global Impressions – Severity (CGI-S) Starting on Day 2 and Continuing through Week 12",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.532+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "01db46dc-49cf-49f1-b494-2a78f8e00dca",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Chartjunk Elimination",
            "slug": "chartjunk-elimination",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-b49e-7453-ab01-b60f338eeda1",
            "version": 1,
            "bodyDocId": null,
            "description": "Remove decorative elements that don't convey data: 3D effects, shadows, unnecessary gridlines",
            "familyLabel": null,
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "Designer",
          "layer": "slide",
          "agents": [
            "Designer"
          ],
          "matchId": "8ca2c4ad-0213-427b-bb69-b1181a4e6c72",
          "evidence": "The chart effectively communicates the data with a clear and simple bar chart.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:41:09.395396+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 36,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 36,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Traction",
          "beatId": "c93e54c1-7fba-4f94-ae19-b53dc410f312",
          "matchId": "eab80cbf-3c50-4c39-9693-c883da1b849f",
          "beatType": null,
          "evidence": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 37,
      "type": "evidence",
      "title": "The slide uses a structured list format to present safety outcomes.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 67,
        "componentCount": 5,
        "textChars": 888,
        "nDataPoints": 4,
        "notes": "The slide uses a structured list format to present safety outcomes.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:57.466+00",
          "seconds": 2.747,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/37",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-37",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.15,
            "w": 0.65,
            "x": 0.26,
            "y": 0.22
          },
          "kind": "list",
          "text": "Virtually all (99%) adverse events (AEs) were mild-to-moderate in severity; Minimal (2.5%) treatment emergent AEs (TEAEs) led to study withdrawal; No drug-related serious adverse events (SAEs)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.466+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6eb4e4f5-2ba5-45f0-b913-1a11db0263da",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.65,
            "x": 0.26,
            "y": 0.62
          },
          "kind": "list",
          "text": "No suicidal or self-injurious behavior; ≤ 2 participants per arm reported suicidal ideation during the study; No indication of increased suicidality or suicide-related risk",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.466+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9bd57df1-4e1a-4df5-ada2-059480034bec",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.65,
            "x": 0.26,
            "y": 0.45
          },
          "kind": "list",
          "text": "Only SAE was in 50 µg dose group and deemed unrelated; AE profile consistent with historical studies and drug class",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.466+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e27bbeee-9420-48f8-92f7-f93aaea06796",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.6,
            "x": 0.04,
            "y": 0.92
          },
          "kind": "source-note",
          "text": "1. Source: Study MMED008 internal study documents and calculations. Safety population. 2. One serious adverse event (SAE) was observed in the 50 µg dose group: panic attack on study day 98 that was deemed not related to treatment. 3. Suicidality assessment based on reported adverse events.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.466+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d8a46ebd-05f9-48fa-ab20-ef2886edc83b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.92,
            "x": 0.04,
            "y": 0.05
          },
          "kind": "title",
          "text": "MM120 was Well-tolerated with Mostly Transient, Mild-to-Moderate Adverse Events Consistent with Drug Class Expectations",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.466+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2185c142-ae53-4836-b95f-486d0a9d07f7",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "List presentation",
            "slug": "list-presentation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
            "version": 1,
            "bodyDocId": null,
            "description": "Bulleted, numbered, or checklist enumerations.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "f0b38644-7847-4291-9e14-d29efeca0864",
          "evidence": "The slide uses a list/bullet format to present information.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:41:09.47464+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 37,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 38,
      "type": "analysis",
      "title": "The table highlights that while adverse events occur, they are largely concentrated on the dosing day, suggesting a favorable tolerability profile.",
      "function": "analyze_data",
      "rawType": "appendix_data",
      "block": null,
      "metadata": {
        "slideType": "appendix_data",
        "slideTypeCanon": {
          "name": "Appendix data",
          "slug": "appendix_data",
          "status": "active",
          "canonId": "019de52d-078a-745b-9ee4-c15f2f539acd",
          "version": 1,
          "description": null
        },
        "function": "analyze_data",
        "functionCanon": {
          "name": "Analyze data",
          "slug": "analyze_data",
          "status": "active",
          "canonId": "019de52d-1590-7413-8c82-cc218cff40b4",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 40,
        "componentCount": 3,
        "textChars": 386,
        "nDataPoints": 150,
        "notes": "The table highlights that while adverse events occur, they are largely concentrated on the dosing day, suggesting a favorable tolerability profile.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:58.009+00",
          "seconds": 3.258,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/38",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-38",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.05,
            "w": 0.4,
            "x": 0.16,
            "y": 0.092
          },
          "kind": "source-note",
          "text": "Source: Study MMED008 internal study documents and calculations. Safety population. High dose groups include 100 and 200 µg dose groups. AFT: After Dosing Day; DD: Dosing Day; TEAE: Treatment-emergent adverse event.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:58.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "203826b1-1282-472c-9461-e6a82e195aca",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.75,
            "w": 0.95,
            "x": 0.03,
            "y": 0.15
          },
          "kind": "table",
          "text": "Table of TEAEs by dose group (25, 50, 100, 200 ug) and placebo, split by DD and AFT.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:58.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8226202b-2ac2-4c9c-9f06-0749b5340832",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.03,
            "y": 0.05
          },
          "kind": "title",
          "text": "Most Common (≥10%) TEAEs in High-Dose Groups Demonstrate Favorable Tolerability Profile",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:58.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ce2dd928-846a-40ff-9e4a-107b68012605",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Table data",
            "slug": "table-data",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4fab-7168-a82f-b847350a006d",
            "version": 1,
            "bodyDocId": null,
            "description": "Tabular layouts of structured data.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "333564e8-1de2-4f1e-a071-1ef4a729ee57",
          "evidence": "The slide contains a table with data.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:41:09.553373+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 38,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 39,
      "type": "setup",
      "function": "transition",
      "rawType": "section_divider",
      "block": null,
      "metadata": {
        "slideType": "section_divider",
        "slideTypeCanon": {
          "name": "Section divider",
          "slug": "section_divider",
          "status": "active",
          "canonId": "019de52d-066a-7402-9554-6ae504999041",
          "version": 1,
          "description": null
        },
        "function": "transition",
        "functionCanon": {
          "name": "Transition",
          "slug": "transition",
          "status": "active",
          "canonId": "019de52d-1365-7149-92aa-66df859e75fd",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 3,
        "componentCount": 2,
        "textChars": 22,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:57.737+00",
          "seconds": 2.849,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/39",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-39",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.1,
            "w": 0.3,
            "x": 0.625,
            "y": 0.23
          },
          "kind": "image",
          "text": "MindMed",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.737+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "69d418e7-d251-4cbb-9290-e8aa0cfd8a66",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.25,
            "x": 0.625,
            "y": 0.6
          },
          "kind": "title",
          "text": "MM402 R(-)-MDMA",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.737+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d5a79dcc-899d-44e3-8b9b-48cf0d9105ba",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 40,
      "type": "resolution",
      "title": "The slide uses a combination of a cellular-level mechanism diagram and a brain-region-level diagram to explain the drug's effect.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 28,
        "componentCount": 3,
        "textChars": 348,
        "nDataPoints": 0,
        "notes": "The slide uses a combination of a cellular-level mechanism diagram and a brain-region-level diagram to explain the drug's effect.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:59.874+00",
          "seconds": 4.943,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/40",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-40",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.65,
            "w": 0.7,
            "x": 0.15,
            "y": 0.14
          },
          "kind": "image",
          "text": "Diagram showing MM-402 entering via SERT, inhibiting VMAT2, and modulating brain regions like the nucleus accumbens, hypothalamus, and amygdala.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:59.874+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2a9df9c8-5ce5-4fda-9a60-113e37354374",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.3,
            "x": 0.545,
            "y": 0.595
          },
          "kind": "list",
          "text": "Improved social perception; More effective communication; Increased interpersonal connection; Decreased stress and anxiety; Increased positive affect",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:59.874+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b66c2f8f-ec4f-418f-8f54-7f8145db201c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.055,
            "w": 0.705,
            "x": 0.038,
            "y": 0.045
          },
          "kind": "title",
          "text": "Differentiated Mechanism of Action Targets Key Pathways",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:59.874+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6443b577-74f2-4933-b279-56de178673f5",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 41,
      "type": "resolution",
      "title": "The slide uses a bar chart to demonstrate efficacy in an animal model and an icon grid to summarize clinical benefits.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 64,
        "componentCount": 5,
        "textChars": 666,
        "nDataPoints": 6,
        "notes": "The slide uses a bar chart to demonstrate efficacy in an animal model and an icon grid to summarize clinical benefits.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:58.848+00",
          "seconds": 3.646,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/41",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-41",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.45,
            "w": 0.4,
            "x": 0.05,
            "y": 0.33
          },
          "kind": "chart",
          "text": "Increased duration of interaction in the three-chamber social interaction test",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:58.848+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9ffd5a15-d390-4c21-a9ea-52b5ca09a693",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.4,
            "x": 0.55,
            "y": 0.18
          },
          "kind": "image",
          "text": "Enhanced pro-social effects with potentially reduced side effects compared to MDMA",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Icon grid",
              "slug": "icon-grid",
              "status": "active",
              "canonId": "019de52c-fdfe-749d-9990-1db465a3eed4",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "icon-grid",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:58.848+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "927a03c4-ed4e-49eb-9c4e-55649dc8ad33",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.45,
            "x": 0.037,
            "y": 0.16
          },
          "kind": "list",
          "text": "MM402 is the serotonergic enantiomer of MDMA\nPotential first-in-class therapy for core symptoms of ASD\nIntend to develop for daily, at-home use",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:58.848+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a7371b92-bed9-49e4-9d97-9cbdc1846fa6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.55,
            "x": 0.17,
            "y": 0.92
          },
          "kind": "source-note",
          "text": "1. “MM402 demonstrates better efficacy than S(+)-3,4-MDMA or (±)-3,4-MDMA in Fmr1 knockout mice, an animal model of autism spectrum disorder”. Presented at ECNP 2023. Data from “stranger” portion of “Duration in the arena” data.\n2. Pitts EG, Curry DW, Hampshire KN et al. 2018; Psychopharmacology; 235(2):377-392.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:58.848+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "46d97f6a-2ab3-4534-bb4b-293e04b6a2e0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.65,
            "x": 0.037,
            "y": 0.045
          },
          "kind": "title",
          "text": "Addressing the Urgent Need For Novel ASD Therapies",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:58.848+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5ad915b9-8133-466c-97f1-bfce618ee050",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "b389321e-53fc-417f-ba4d-519427354166",
          "evidence": "Use of icons to categorize benefits",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 10:50:58.848+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 41,
          "frameworkName": "iconography"
        }
      ],
      "arcBeats": [],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 42,
      "type": "setup",
      "title": "This slide serves as a divider or cover page within the deck.",
      "function": "front_matter",
      "rawType": "cover",
      "block": null,
      "metadata": {
        "slideType": "cover",
        "slideTypeCanon": {
          "name": "Cover",
          "slug": "cover",
          "status": "active",
          "canonId": "019de52d-05f2-729d-9f93-e0504f0a2410",
          "version": 1,
          "description": null
        },
        "function": "front_matter",
        "functionCanon": {
          "name": "Front matter",
          "slug": "front_matter",
          "status": "active",
          "canonId": "019de52d-133d-73f0-9e26-201eda96b098",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 1,
        "componentCount": 1,
        "textChars": 12,
        "nDataPoints": 0,
        "notes": "This slide serves as a divider or cover page within the deck.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 10:50:57.466+00",
          "seconds": 2.025,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de077-691b-72c2-80d2-a28de652ce70/42",
        "deck": "/decks/019de077-691b-72c2-80d2-a28de652ce70",
        "deckAnchor": "/decks/019de077-691b-72c2-80d2-a28de652ce70#slide-42",
        "deckJson": "/decks/019de077-691b-72c2-80d2-a28de652ce70.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.211,
            "w": 0.5,
            "x": 0.319,
            "y": 0.394
          },
          "kind": "image",
          "text": "MindMed logo",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 10:50:57.466+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "13400e5d-2c1b-4cb7-ac97-d57d0b4afe29",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 42,
          "from": 3,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "6a4562d9-e1ba-4048-9ae4-0523b32c6d36",
          "evidence": "The document follows the golden circle framework, starting with the company's vision (why) and presenting its approach (how) and solution (what).",
          "position": 1,
          "objective": "Presenting the company's vision and approach",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:45:42.047737+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    }
  ],
  "arcBeats": [
    {
      "from": 9,
      "to": 9,
      "label": "Problem",
      "description": "The problem statement is clearly presented on page 9, highlighting the need for novel therapies in brain health."
    },
    {
      "from": 10,
      "to": 10,
      "label": "Solution",
      "description": "The solution is presented on page 10, outlining the clinical rationale and mechanism of action for MM120."
    },
    {
      "from": 16,
      "to": 36,
      "label": "Traction",
      "description": "The traction section spans multiple pages, showcasing the results of clinical trials and the potential of MM120."
    },
    {
      "from": 5,
      "to": 6,
      "label": "Roadmap",
      "description": "The roadmap is presented on pages 5 and 6, outlining the next steps and anticipated milestones for the R&D pipeline."
    }
  ],
  "loops": [
    {
      "from": 9,
      "to": 10,
      "label": "Cost Of Inaction",
      "description": "Highlighting the need for novel therapies"
    },
    {
      "from": 3,
      "to": 42,
      "label": "Golden Circle",
      "description": "Presenting the company's vision and approach"
    }
  ]
}